DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGLV4-69; IGLV8-61; IGLV4-60; IGLV7-46; IGLV5-37; IGLV2-18; IGLV3-16; IGLV3-9; TRBV19; TRBV20-1; TRBV24-1; TRBV25-1; TRGV2; TRGJ1; IGKV2D-29; IGKV1-27; TRAV12-2; TRAV6; TRAV7; TRAV36DV7; TRAV23DV6; TRAV18; TRAJ3; TRAJ42; TRDJ1; IGLV5-45; TRAV30; TRAV27; TRAV9-2; TRAV26-1; TRBV16; TRBV18; TRBJ2-6; TRBJ2-7; IGKJ1; TRBJ2-2; TRBJ2-1; TRAV14DV4; TRBV13; TRBV6-6; TRBV6-8; TRAV8-3; TRAV8-1; TRAV16; TRAV19; TRGV5; TRBV9; IGLV9-49; TRBJ2-3; TRAV2; TRAV13-2; TRAV8-2; TRAV1-2; TRAV10; TRAV13-1; TRAV3; TRAV12-1; TRAV1-1; TRAV5; TRAV8-6; TRAV39; TRAV38-1; TRAV26-2; TRAV41; TRAV4; TRAV12-3; TRAV24; TRAV34; TRAV20; TRAV17; TRAV25; TRAV22; TRAV21; TRAV40; TRBV12-4; IGKV6-21; TRGV8; TRGV4; TRBV5-4; IGKV1-8; IGKV1-9; IGKV1-6; TRBJ1-3; TRBJ1-6; TRBJ1-2; TRBJ1-1; TRBJ1-4; TRBJ1-5; TRBV6-2; TRBV10-1; TRBV6-5; TRBV30; TRBV11-1; TRBV27; TRBV6-1; TRBV7-7; TRBV10-3; TRBV10-2; TRBV7-6; TRBV6-4; TRDV1; TRBV2; TRBV12-5; TRBV7-4; TRBV7-2; TRBV4-2; TRBV3-1; TRBV4-1; TRBV5-1; TRBV11-2; TRBV5-5; TRBV5-6; TRBV11-3; TRBV14; TRBV28; TRBV29-1; TRAV38-2DV8; TRDV2; TRDV3; PIK3CD; SH2D1B; TNFRSF13B; SH2D1A; LILRA1; EOMES; CD160; CD4; TRBV12-3; TRAV8-4; TRAC; IGHM; HLA-B; HLA-DRA; TRGV3; TRGC2; CD3D; TRBV7-9; TRAV29DV5; HLA-DPB1; PRKCB; FYN; CD3E; LYN; CD3G; TRGC1; TRAV35; TRBD1; HLA-C; CD8B; CD79A; HLA-E; HLA-DOB; CTLA4; LAG3; TFEB; HLA-DPA1; CD247; CTSS; HLA-DMA; HLA-DMB; CD6; GPR183; CD79B; CD86; TXK; ZAP70; IL2; TNFRSF17; BTK; SLAMF1; ADGRE1; PDCD1; HLA-DRB5; CLEC6A; LAIR1; TRAT1; BTNL8; BTLA; SKAP1; LAX1; LILRB2; LILRB1; PRR7; CLEC4C; TNFRSF14; ORAI1; SIGLEC10; TRGV9; CD244; MCOLN1; LAT2; UNC93B1; CD84; CLEC4A; SIT1; IFNG; IFNA5; IFNB1; IFNA21; IFNW1;	GO:0002250~adaptive immune response	200	347	57.6368876080692	0	0	0	0	0	0	0
down	PCDH17; PCDH7; DSCAM; MPZL2; CDH16; CEACAM5; CDH1; CEACAM1; DSG3; CEACAM6; CDH13; DSG1; DSC2; PCDH1; CDH17; DSG2; FAT1; DSC3; IGSF11; CADM3; NECTIN2; PCDHB18P; CDHR2; PCDH11X; PCDHAC1; CLSTN2; CDHR5; ROBO2; PCDH18; PCDHB16; CELSR1; FAT2; PCDH10; CDH22; PCDHB8; PCDHB10; PCDHGC3; PCDHGB4; PCDHA7; PCDHA6; PCDHA4; PCDHA12; PCDHB9; PCDHB7; PCDHB6; PCDHB5; PCDHB4; PCDHB3; PCDHB2; PCDHB15; PCDHB14; PCDHB13; PCDHB12; PCDHB11; PCDHGC4; PCDHGB6; PCDHGB5; PCDHGA2; PCDHGA10; PCDHA9; PCDHA8; PCDHA5; PCDHA3; PCDHA13; PCDHA11; PCDHA10; PCDHAC2; CDH5; NECTIN4; CNTN4; VSTM2L; CDH19; PALLD; IGSF9; CDH11; ROBO4; IGSF21; CDH6; CDH3; CDH24; CDH10; CDH8; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	83	165	50.3030303030303	0	0	0	0	0	0	0
down	EVPLL; LCE2B; AGPAT2; FOXN1; TGM5; KRT34; SCEL; GJB5; KRT14; PTHLH; KRT5; DSP; KRT15; FGF7; SPRR1B; SPRR2E; SPRR2D; CRABP2; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KLK7; ALDH3A2; EMP1; ELF3; FABP5; BNC1; COL7A1; LAMB3; LAMC2; KRT32; KRT31; CDSN; CST6; LAMA3; ZNF750; GRHL2; CERS3; ACER1; GRHL3; EVPL; HOXB13; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; POU2F3; COL17A1; KLK5; KRTDAP;	GO:0008544~epidermis development	56	82	68.2926829268293	0	0	0	0	0	0	0
down	CCL21; NRG2; FGF10; SPRY2; RAMP3; FGF19; EGFR; TGFA; ERBB2; FGF1; MET; CSF3; TXN; FGF5; F3; AREG; PDGFRA; FGF7; FGFR2; ERBB3; FGFR4; FGFR3; IGFBP5; CALCR; BTC; THPO; AKR1C3; AKR1C2; CX3CL1; TEK; MST1R; PTK2; C1QBP; STK3; SEMA5A; IL18; ANGPT1; FAM110C; TNFAIP8L3; EPGN; KLB; HBEGF; MEIS3; CCL19; P2RY12; FGF22; FGF20; NOX4; AXL;	GO:0051897~positive regulation of protein kinase B signaling	49	165	29.6969696969697	0.00010361261202707	0.00933920593098326	0.748186671447479	0.756475680409644	0.623229861342831	0.748186671447479	0.0884707717597723
down	PIFO; NTRK2; FLT4; ERBB2; EPHA10; EPHB3; TYRO3; ROS1; EPHA8; FGFR2; DDR1; KDR; MET; EGFR; ROR1; ERBB3; EPHA1; EPHA3; EPHA2; MST1R; TEK; TIE1; EPHA5; AXL; PDGFRA; EPHA6; FGFR4; FGFR3;	GO:0033674~positive regulation of kinase activity	28	73	38.3561643835616	0.00010811990713399	0.00954109523792463	0.780625729507456	0.78938344198531	0.635096334505096	0.780625729507456	0.0903832794105452
down	WNT9A; WNT9B; FZD7; GJB3; YES1; ZNF35; FGFR2; TNC; EPHA3; AQP1; PCK1; PPARG; WNT5A; YAP1; SOX9; WNT3; WNT3A; WNT7B; PTK6; BRINP3; HDAC2; WNT5B; NDUFA13; FZD4; FZD10; BRINP1; RARG;	GO:0071300~cellular response to retinoic acid	27	69	39.1304347826087	0.00010907818737282	0.00954109523792463	0.787435434644418	0.796379846008989	0.637622786934657	0.787435434644418	0.0903832794105452
down	ERBB2; NTF3; ERBB3; PTPRG; BDKRB2; TEK; CNKSR1; NRTN; AXL; MET; BLNK; FRK; BCAR1; TIE1; YES1; KDR; NTF4; EPHA6; FLT4; EGFR; EPHA10; DDR1; PTK6; FGFR3; EPHA3; EPHB3; TYRO3; EPHA2; EPHA8; MST1R; EPHA5; EPHA1; FGFR2; NTRK2; FGFR4; PDGFRA; ROR1; EFS; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	39	120	32.5	0.00010977290781888	0.00954109523792463	0.792340848636702	0.801451999985669	0.639427188044997	0.792340848636702	0.0903832794105452
down	RAMP2; MB; RBP4; ERBB2; TH; GLI2; GLI3; MYL2; MTHFD1; BMP2; GYS1; GJA1; WT1; PTN; ERBB3; EDNRA; ITGA3; GNA11; APLNR; PPARG; CDKN1A; ID1; OXCT1; RIPPLY3; FGF12; ISL1; TGFB2; CXADR; IRX4; TEK; FOXF1; FOXC1; FOXL1; CALCRL; RBM20; SYPL2; BVES; DNAH5; FOXJ1; ALPK3; TBX5; FOXC2; PKP2; STRA6; FLRT3; HSPB7; PDLIM5; PRICKLE4; PDLIM1; SOX17; PDLIM3; PDLIM4; SOX9; POPDC3;	GO:0007507~heart development	54	190	28.4210526315789	0.0001234824553582	0.0104830861229098	0.891049397864798	0.901545406570245	0.675572513264732	0.891049397864798	0.0993068068711434
up	SASH3; CD4; HLA-DPB1; CD3E; CCL5; CD1D; HLA-DPA1; HLA-DMB; CD40LG; CD6; CORO1A; CD70; IL15; AIF1; NCKAP1L; PRKCQ; CLECL1; LILRB2; IL21; TNFSF13B; CD80; CD86;	GO:0042102~positive regulation of T cell proliferation	22	61	36.0655737704918	0.00013318472873691	0.0255483053559677	0.584680959155046	0.587611023187258	0.583482296596414	0.584680959155046	0.22915328604849
down	PEX7; SLC27A2; SCP2; CPT2; ACAT1; ABCD3; ACADL; ECHS1; ECI1; ACADVL; HSD17B4; HADHB; EHHADH; HADH; MCAT; CPT1C; MECR; CROT; ECHDC2; ACAT2;	GO:0006635~fatty acid beta-oxidation	20	43	46.5116279069767	0.00013726800807256	0.0115194681257219	0.990388678243566	1	0.70336127336383	0.990388678243566	0.109124506181375
down	WNT9A; WNT9B; LMX1B; OPHN1; FZD7; HSPA5; EDN3; PTPRD; SMARCA1; HOXC8; ID1; WNT5A; WNT3; WNT3A; WNT7B; FZD5; CTF1; NTRK2; PCSK9; WNT2B; HOXD1; WNT5B; NGRN; IL1RAPL1; FZD4; FZD10; FUT9; EMX2; LHX5; ERBB2; WNT4; LHX6; MET; LHX1; VAX2; LHX3; EN1; VAX1; WNT10A; LHX2; EN2;	GO:0030182~neuron differentiation	41	131	31.2977099236641	0.00014586228725543	0.0121015972642268	1	1	0.717798641302016	0.999999999999988	0.114639045054162
down	SPTBN2; DSCAM; DRD1; ACHE; FZD5; ADGRF1; DNER; SHANK3; SLITRK6; ADGRL3; PCDHB16; FLRT3; PCDHB10; SHANK2; PCDHB9; PCDHB6; PCDHB5; PCDHB4; PCDHB3; PCDHB2; PCDHB14; PCDHB13; PCDHB11; PCLO; CDH1;	GO:0007416~synapse assembly	25	63	39.6825396825397	0.00016187849512616	0.0131319432546238	1	1	0.74027614677548	0.999999999999988	0.124399564912451
down	TNFRSF11B; ENSA; ACSL3; LDHA; ASS1; APOA1; HMGCR; PKM; NQO1; IGFBP2; UGT1A1; AHCY; ALDH3A1; PPARG; AKR1C3; GCGR; GCLC; STAR; OXCT1; SST; AACS; SFRP2; LIPG; SLC27A4; BCKDHB;	GO:0007584~response to nutrient	25	63	39.6825396825397	0.00016187849512616	0.0131319432546238	1	1	0.74027614677548	0.999999999999988	0.124399564912451
up	TNFSF14; GRAP2; CD160; LCK; FYN; CD3E; LYN; CTLA4; PTPN6; CD40LG; CD80; CD86; PDCD1; BTLA; TNFRSF14; TMIGD2; HHLA2; TNFSF13B; ICOS; CD5;	GO:0031295~T cell costimulation	20	53	37.7358490566038	0.00016220815538581	0.0298192658984252	0.71193159398833	0.715662381562204	0.710309512434472	0.71193159398833	0.267461292362457
down	TNFRSF11B; KCNK3; AGPAT2; TP73; SPINK4; BCAR3; APOA1; CYP1A1; APOD; INHBA; MGST1; ITGA2; IGFBP2; AOC1; DRD1; MDK; COMT; CDH3; GAL; CCNO; UQCRC2; CCND1; ITGA3; AK4; ABCD3; AQP1; ALDH3A1; ADRA1A; HNF1B; CDKN1A; GATA4; SLC6A11; VEGFC; S100A10; SST; TGFB2; HSD11B2; HMGCS1; EMX2; CA9; HADH; TFAP2B; GATA6; SFRP2; TIMP4; NPAS2; GABRG3; RAB6C; WFDC1; SRP68; NPC1L1; VAV3; MYO6; ANXA1;	GO:0042493~response to drug	54	193	27.979274611399	0.00017174679784215	0.0137793777037974	1	1	0.754140189324898	0.999999999999988	0.130532744307525
up	IFNA21; IFNA5; IFNB1; HLA-B; HLA-H; HLA-A; HLA-C; IRF1; IFITM1; HLA-E; HLA-G; SP100; PSMB8; TYK2; HLA-F; IFNAR2; IFI35; IRF9; IFITM2; IRF8; IRF5; IRF4; ISG20;	GO:0060337~type I interferon signaling pathway	23	67	34.3283582089552	0.00017222266592065	0.0303938560816766	0.755713058059819	0.759846402041915	0.753990831400613	0.755713058059819	0.272615028658806
up	SH2D1A; LTA; ALOX5; MS4A1; CCL2; ST6GAL1; TFEB; GATA3; GPR183; PSMB10; CCR2; CCR6; MEF2C; BST1; PDCD1; IFNB1; IFNW1; IFNG; IFNA5; IFNA21; AIRE;	GO:0006959~humoral immune response	21	58	36.2068965517241	0.00017929708259256	0.0304253357076309	0.78657630133359	0.791058728398404	0.784962627590257	0.78657630133359	0.27289738240519
down	PSMD11; PSMD12; PSMD14; UBE2C; PSMD3; BUB1B; PSMD10; CDK1; CCNB1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PLK1; PSMA6; PSME3; PSMC5; PSMC6; CDC20; PSMD2; MAD2L1; PSMD5; PSMB7; PSMD1; CDC23; ANAPC7;	GO:1901990~regulation of mitotic cell cycle phase transition	29	80	36.25	0.00018104718186196	0.0142131771481093	1	1	0.767216552673785	0.999999999999988	0.134642148459318
down	NDUFS8; NDUFAB1; NDUFS4; NDUFB5; NDUFB3; NDUFC1; NDUFS5; NDUFS7; NDUFS3; NDUFB6; NDUFB4; NDUFA10; MT-ND6; NDUFB7; NDUFS1; NDUFA8; NDUFA6; NDUFA5; NDUFA9; NDUFA11; TIMM21; ACAD9; TIMMDC1; NDUFA13; BCS1L;	GO:0032981~mitochondrial respiratory chain complex I assembly	25	64	39.0625	0.00019673850894474	0.0151198721453223	1	1	0.786167081743218	0.999999999999988	0.143231316183742
down	FZD9; TERT; TOX3; HRAS; TGFB3; EN2; MDK; ERBB3; PTPRZ1; CNTFR; GABRB3; AXL; GABRA5; GDNF; GABRB2; GCLC; NES; STAR; DLX1; ISL1; STXBP1; EN1; TYRO3; GRIK2; ANGPT1; SIX1; NTRK2; BHLHB9; SLC30A10; UNC5B; NDNF; TFAP2B; VSTM2L; LGMN; FAIM2; FOXQ1; FGF20; SIX4; BOK; APOE; NTF4; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	42	138	30.4347826086957	0.00020101602434985	0.0152876874351904	1	1	0.790610055678667	0.999999999999988	0.144821038941485
down	B4GALT4; UGDH; B4GALT2; XYLB; CS; PGM3; GCNT3; TFF1; AMY1A; ALDH2; GPI; ADRB3; SI; ABO; FUT1; ME1; IDH3A; B4GALNT1; GLO1; FUT2; HYAL1; HYAL2; GCKR; GALNT3; MDH1B; CHST3; GALNT7; KLB; GLB1L2; NANP; ST8SIA2; RPE; CHST6; SLC2A8; A4GNT; DHDH; FUT9; GBE1;	GO:0005975~carbohydrate metabolic process	38	121	31.404958677686	0.0002356036184995	0.0175524695782129	1	1	0.826832362473766	0.999999999999988	0.166275435122666
down	CXCL11; CXCL10; ACKR3; XCR1; CXCL12; CX3CL1; FOXC1; GPR17; ACKR1; CCL26; CCL16; CCL22; CCL21; CCL11; CCL13; CXCL9; CCL1; CCL14; TFF2; CXCL1; CXCL13; CCL20; CXCL6; CCL17; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	26	70	37.1428571428571	0.00028073550781038	0.0199513481565272	1	1	0.865764005209609	0.999999999999988	0.189000133640916
up	HLA-B; HLA-H; HLA-A; HLA-C; HLA-E; HLA-G; HLA-F; B2M;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	8	9	88.8888888888889	0.00028690591676316	0.0468825520281149	1	1	0.999999999574447	0.999999999574447	0.420508942017649
down	TLL1; CTSV; MMP1; GSN; CAPN1; MMP3; MMP7; MMP10; CTRB1; CAPN2; CMA1; MMP12; MMP13; KLK7; MMP15; MMP16; ADAM15; TPSAB1; WDR72; CTRB2; HTRA1; CAPNS2; KIF9; ADAMTS5; KLK5;	GO:0022617~extracellular matrix disassembly	25	66	37.8787878787879	0.00028693214031438	0.0199513481565272	1	1	0.870773706200235	0.999999999999988	0.189000133640916
down	CLDN5; IRF6; WNT9B; TBX3; SNAI2; TCF21; TFAP2A; INHBA; GLI3; PDGFRA; MSX1; GABRB3; MEOX2; EPHB3; DLX5; DLX6; ASPH; FOXF2; TBX2; ALX1; VAX1; FRAS1; ALX4; PAK1IP1; INTU;	GO:0060021~roof of mouth development	25	66	37.8787878787879	0.00028693214031438	0.0199513481565272	1	1	0.870773706200235	0.999999999999988	0.189000133640916
down	TNFRSF11B; CYP27B1; SLC34A2; LDHA; CA2; APOA1; KRT19; GLI3; TGFB3; IGFBP2; GSTM3; COMT; GAL; DTYMK; CCND1; CD24; CTNNA1; PPARG; STAR; TEK; CAV1; ZNF366; GATA6; CITED4;	GO:0043627~response to estrogen	24	62	38.7096774193548	0.00029108620611684	0.0200492489703685	1	1	0.873454870020938	0.999999999999988	0.189927553019015
down	E2F8; POLR3G; BUB1; CYP1A1; IGF1; CDK1; PAX1; ITGA2; EDNRA; IL12A; IL12B; CDC25C; CKS2; THPO; YAP1; EMP2; DLX5; WNT3A; CKS1B; OCA2; PRDX1; FOXC1; IL18; KANK1; MELK; FAM83B; GRHL2; DUX4L9; CSPG4; FAM83A; OGFOD1; RHBDF1; AURKB; GNL3; SDCBP2; TP63; FAM83D; SIX2; PAK1IP1; PAK5; LIPG; TACC2;	GO:0008283~cell population proliferation	42	142	29.5774647887324	0.00033097509402924	0.0225836370234344	1	1	0.899239919091805	0.999999999999988	0.213935939668851
down	AKR1B10; GPC4; LRAT; ADH1B; APOA1; APOE; APOC3; RBP4; APOA4; RBP1; RBP3; SDC1; SDC4; GPC1; ADH7; AKR1C3; AKR1C1; GPIHBP1; RDH10; RDH12; RARRES2; STRA6; BCO2; BCO1;	GO:0001523~retinoid metabolic process	24	63	38.0952380952381	0.00035145719559337	0.0236953251100099	1	1	0.909922679391246	0.999999999999988	0.224467017332445
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; NQO1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; PSMB7; PSMD1;	GO:0006521~regulation of cellular amino acid metabolic process	21	51	41.1764705882353	0.00035375844911533	0.0236953251100099	1	1	0.91115670076287	0.999999999999988	0.224467017332445
down	PDLIM1; SLC9A3R1; ABLIM3; ADRA2A; CXCL1; ITPKA; PFN2; ARFIP2; PFN3; RND3; FGD1; SPIRE1; ARHGEF5; KANK1; TRIP10; FSCN1; ABLIM2; FGD5; POF1B; SPIRE2; PALLD; ARPC1A; FOXJ1; RHOJ; SHROOM4; DAAM1; SHROOM2; SPECC1L-ADORA2A; SMTNL2; SMTN; PDLIM4; CAPZA3; SSH3; ARFGEF3; PDLIM5; OPHN1; PDLIM3; CSRP3; PRICKLE4; AMOTL2; AMOTL1; EHBP1; CSRP2; SHROOM3; RHOV;	GO:0030036~actin cytoskeleton organization	45	157	28.6624203821656	0.00036850885730899	0.024458937883754	1	1	0.918871526628805	0.999999999999988	0.231700759892359
down	TBX3; FOXN1; TREH; PITX3; GMNN; ONECUT2; HRAS; TH; DCN; BMP2; ELN; ITGA2; FGFR2; PAX3; LHX1; VEGFC; EFNB2; HCCS; NKX6-1; FGD1; PHLDA2; LHX3; LAMC2; LAMA1; ATRNL1; LAMB4; NTN3; LAMB3; NTNG1; EGFLAM; NTN4; LAMA3; LAMA5; LAMB2; LAMC3;	GO:0009887~animal organ morphogenesis	35	111	31.5315315315315	0.00038120177059453	0.0250734606046006	1	1	0.923548947741392	0.999999999999988	0.237522164814682
up	IFNG; HLA-B; HLA-H; HLA-DRA; HLA-DRB1; HLA-A; HLA-DPB1; HCK; HLA-C; IRF1; HLA-E; HLA-G; HLA-DPA1; SP100; PTAFR; HLA-F; B2M; IRF9; IRF8; IRF5; IRF4; HLA-DRB5; TRIM34;	GO:0060333~interferon-gamma-mediated signaling pathway	23	72	31.9444444444444	0.00040291186556551	0.0612981776163809	1	1	0.999999999574447	0.999999999574447	0.549808632465581
down	SMIM22; MYO1C; RHOD; PODXL; CLDN4; CLDN3; SPRY2; SNAI2; CPNE3; CLDN1; ONECUT2; FAM107A; EGFR; PLAU; HRAS; IGF1; FGF1; ADRA2A; HSPA5; BMP2; F3; PDGFRA; NTF3; EPHA1; DRD1; MDK; SERPINB3; CDH5; KDR; CEACAM6; MCAM; CCL11; CDH13; BCAR1; TNFAIP6; CAV1; PTK2; TJP1; FOXF1; LAMC2; GRB7; GPNMB; TRIP6; FAM110C; FAM83H; PDPN; ARHGEF39; SH3RF2; HAS2; HBEGF; SMO; WNT5B; SPHK1; CCL26; CXCL12; SEMA6D; SEMA4B; SEMA3F; SEMA3E;	GO:0030335~positive regulation of cell migration	59	226	26.1061946902655	0.00040800135148888	0.0263612200638969	1	1	0.932640976851216	0.999999999999988	0.249721175527887
down	SMIM22; CXCL11; LAMA5; RBFOX2; PLAU; CXCL10; INHA; JUP; FUT3; ERBB3; AGTR1; NOS2; HOXD13; PLA2G4A; SOX9; JAG1; PTK2; CXCL9; SQLE; TRNP1; FA2H; PLCD3; NKX2-3; BIRC7; GNL3; CDCA7; ACE2; EGLN3; SGK2; FANCL; DHCR7; OSGIN1; JAG2; FRK; TGFB3; ANXA1; YES1; TGFB2; TFAP2B; DUSP15; GKN2; TFAP2A; BCL6B; PTK6; TFAP2C; GKN1;	GO:0042127~regulation of cell population proliferation	46	163	28.2208588957055	0.00042403511887301	0.0271568456394023	1	1	0.938028525918887	0.999999999999988	0.257258176983573
down	GCNT3; MUC1; MUC5AC; MUC3A; MUC2; GALNT3; MUC21; MUC17; B3GNT6; GALNT7; GALNT12; MUC20; MUC15; GALNT4; MUCL1; GALNT14; MUC4; B3GNT5; MUC13; MUC5B; B3GNT2; A4GNT; B3GNT3;	GO:0016266~O-glycan processing	23	60	38.3333333333333	0.00043046142069014	0.0272502573376469	1	1	0.940208044945388	0.999999999999988	0.258143070741796
down	PSMD11; PSMD12; PSMD14; AURKA; PSMD3; PSMD10; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; PSMB7; PSMD1; FBXL7;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	22	56	39.2857142857143	0.00043474845036495	0.0272502573376469	1	1	0.941665143490487	0.999999999999988	0.258143070741796
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; HRAS; MUC1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; MUC5AC; MUC3A; MUC2; PSMD2; PSMD5; MUC21; MUC17; CLEC10A; MUC20; MUC15; MUCL1; MUC4; PSMB7; PSMD1; MUC13; MUC5B; FBXW11;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	35	112	31.25	0.00043669087912678	0.0272502573376469	1	1	0.942373271202022	0.999999999999988	0.258143070741796
down	TAX1BP3; NGFR; ADRA2A; AGTR1; CDH13; ARHGAP29; PDPN; EPS8L1; CNKSR1; RTKN; EPS8L2; CELSR1; HACD3; CTNNAL1; VANGL2; RHOD; CDC42EP5; CDC42EP1; RHOJ; RND2; RHOV; EPS8; C15orf62; RND3; ARHGDIG; RND1; EPS8L3;	GO:0007266~Rho protein signal transduction	27	77	35.0649350649351	0.00045330959583311	0.0280475708404881	1	1	0.947946838339907	0.999999999999988	0.265696062018799
down	TMPRSS2; CD5L; LRP4; LRP5; EPN2; ZFYVE9; HRAS; LDLR; CFI; GHR; NME1; RAB5A; ENDOU; RAB1A; TMPRSS15; ANK2; LGALS3BP; MYO1E; RIN1; ENPP2; CLINT1; TRIP10; SCARA3; ARC; ILDR1; CLEC10A; NOSTRIN; CLEC4F; EHBP1; STEAP2; DNER; SSC4D; SNX33; HOOK2; HHIPL1; SORT1; SH3GL3; TMPRSS13; TMPRSS4; EHD2; DMBT1; PACSIN3; RAB22A; MYO6; EQTN; RHOJ; WIPF3; RHOV;	GO:0006897~endocytosis	48	174	27.5862068965517	0.00049338597728743	0.0302706808418112	1	1	0.961590538351249	0.999999999999988	0.286755695886752
down	C2CD4B; DLL1; LAMA5; GSN; PRLR; FUT1; LAMA1; EPHA8; GPR4; SOX9; PPP2CA; FUT2; IL18; LAMA3; C2CD4A; LMO7; SPINK5; FAF1; JAG2; PTK2;	GO:0030155~regulation of cell adhesion	20	49	40.8163265306122	0.00052887943052559	0.0316503993628474	1	1	0.969476025731227	0.999999999999988	0.299825839458849
down	JUP; DSP; DSC2; CAV1; DLG1; DSG2; TRPM4; PKP2; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	9	11	81.8181818181818	0.00057120844511438	0.0336322004659684	1	1	0.977765874422485	0.999999999999988	0.318599541887426
down	UGT1A9; PEX11A; TNFRSF21; ZMPSTE24; SERPINA3; APOA1; HMGCR; CYP1A1; FABP1; ALAS1; FGFR4; CPT2; FDFT1; HNF4A; ME1; HMGCS2; HMGCS1; CYP4A11; FHL2; TNFAIP8L3; ANGPTL8; LSR; ACER1; NPAS2; C1QTNF2; ANGPTL4; GRHL1; RGL1; PPARG; PSAPL1;	GO:0019216~regulation of lipid metabolic process	30	92	32.6086956521739	0.00061199158377511	0.0351822878200168	1	1	0.98570959294674	0.999999999999988	0.333283598061063
down	DEFB4A; KRT6A; HRG; GAPDH; S100A9; S100A7; H2BFS; DEFB1; ROMO1; CXCL6; DEFA5; PGLYRP4; PGLYRP3; CCL13; DEFB126; RNASE7; CXCL9; CXCL1; DEFA6; CXCL10; CXCL11; CXCL13; REG1A;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	23	62	37.0967741935484	0.00062176096776689	0.0354646627005163	1	1	0.987592582719233	0.999999999999988	0.335958549634889
down	PLD2; SPTBN2; OBSL1; KRT6A; APOE; KRT6B; KRT16; KRT13; KRT5; DES; KRT15; KRT4; MDK; CTNNA2; SOX9; CCL11; FGD1; ANK2; KRT76; DST; KRT31; UGT8; SH3D19; FGD5; LARP4; ARC; PALLD; NECTIN2; CCL13; GAN; PAK6; KRT84; MARK1; PAK5; WASF3; PCLO; ARHGAP10; AJUBA; MAST4; PACSIN3;	GO:0007010~cytoskeleton organization	40	139	28.7769784172662	0.00070562873847179	0.0382409392913825	1	1	0.999999999999988	0.999999999999988	0.362258358679432
down	CACNA1G; DLD; SLC1A6; DLG1; GRIK3; NEDD4L; RIMS4; POPDC3; HCN3; RIMS2; HCN4; GABRA3; GABRB2; RIMS1; GABRA4; BVES; GABRG3; CHRNA5; GABRP; GABRD; GABRA5; GABRA1; HTR3B; CHRNA7; KCNH5; GABRQ; GABRA2; HTR3A; CHRNB4; GABRB3; PIEZO2; GABRE;	GO:0042391~regulation of membrane potential	32	102	31.3725490196078	0.00070898518837281	0.0382409392913825	1	1	0.999999999999988	0.999999999999988	0.362258358679432
down	KCNU1; KCNK1; KCNQ2; ABCC9; KCNK2; ATP1B1; AQP1; SLC1A3; ATP1A2; ATP1B3; KCNJ8; LRRC38; LRRC55; KCNB2; CCDC51; KCNC2; P2RY12; KCNN2; SLC24A3; KCNIP1; HCN3; KCNIP3; HCN4; KCNS3; KCNK15; SLC9A4; KCNQ4; KCNK5; KCNK6; KCNK10; KCNK7; SLC9A2; KCNF1; KCNH5; KCNV1; KCNN3; KCNK3;	GO:0071805~potassium ion transmembrane transport	37	125	29.6	0.00071233635716039	0.0382409392913825	1	1	0.999999999999988	0.999999999999988	0.362258358679432
up	PIK3CD; F13A1; IL2RA; CD4; IGHE; PF4; ITGB2; FYN; FCER2; CSF1R; HCK; VIM; ALOX5; CCL2; CCL5; OSM; IL2RB; CD36; TNFRSF1B; S1PR1; FPR1; IL10; GATA3; IL32; PRTN3; PTAFR; PTPN6; CASP1; TYK2; IL2RG; CD80; IL13; OPRM1; FLT3; OPRD1; CCR2; CD86; STAT5A; IL12RB1; FASLG; CEBPD; CCR5; IL2; IL5RA; IL10RA; IL16; STAT4; IRF4; BATF; IL31; INPP5D; IL22; IL26; IL20; IFNA21; IFNA5; IFNB1; IFNW1; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	59	278	21.2230215827338	0.00073595194025422	0.0983945442545945	1	1	0.999999999574447	0.999999999574447	0.882541242208737
down	NDUFA4; COX7A2P2; ATP2C2; SLC2A10; CYB5A; COX6C; COX8A; COX6A1; COX7A2; COX5A; COX7A1; COX7B; SLC15A1; SLC11A2; CLCN3; SLC25A3; COX10; SLC9A4; OTOP1; OTOP3; OTOP2; SLC4A11; ATP6V1C2; MFSD3; COX4I2; NOX5; ATP6V0A4; NDUFA4L2; ASIC5; SLC2A8; SLC9A2; ATP6V1D; ATP1A2; ATP12A; ATP4A;	GO:1902600~proton transmembrane transport	35	116	30.1724137931034	0.00073693396925911	0.0389880790547883	1	1	0.999999999999988	0.999999999999988	0.369336051576387
down	CLDN5; SEMA3E; SPRY2; PGK1; CXCL10; HRG; DCN; COL4A2; HOXA5; PTN; GADD45A; EPHA2; THBS2; TIE1; PPARG; GPR4; EFNA3; TGFB2; TEK; FOXC1; ECSCR; DAB2IP; SPRED1; SULF1; IL17F; SPINK5; STAB1; PLK2; TNMD;	GO:0016525~negative regulation of angiogenesis	29	89	32.5842696629214	0.00075417515044606	0.03930891547804	1	1	0.999999999999988	0.999999999999988	0.372375351296672
down	MYO1B; SORBS2; TF; ALDOA; TMSB15A; NCK1; CCL11; EMP2; BCAR1; CGNL1; DLG1; FAT1; FHOD3; PDLIM3; POF1B; RND1; TRPV4; SHROOM4; SHROOM3; MYO5B; MYO6; RND3; SHROOM2; RHOJ; LMOD1; RHOV; RND2; MYO1C; RHOD; MYO1D; MYO19; MYOM3; ACTC1; MYO1E; MYO5C; MYO1A;	GO:0007015~actin filament organization	36	121	29.7520661157025	0.00077185562000325	0.03930891547804	1	1	0.999999999999988	0.999999999999988	0.372375351296672
down	SLC9A3R1; MYL12B; SEMA3E; PLXNB1; ZMPSTE24; FN1; ALDOA; ANXA1; S100B; EZR; PTN; KDR; CCL11; FGD1; CDC42EP1; PTK2; EPS8; DLG1; BAMBI; CDC42EP5; FGD5; CYFIP1; MYH14; PDPN; BVES; SHROOM3; FBLIM1; FERMT2; S100A13; CCL13; MYO10; PALMD; PARVA; WASF3; BAIAP2; RND2; RHOV; RND3; WIPF3; RND1; RHOJ; RHOD; C15orf62; PLXNA2;	GO:0008360~regulation of cell shape	44	159	27.6729559748428	0.000779659493776	0.03930891547804	1	1	0.999999999999988	0.999999999999988	0.372375351296672
down	TBX3; HOXC11; LRP4; LRP5; TULP3; GLI2; GLI3; BMP4; HOXA11; HOXD12; HOXD13; WNT5A; TBX2; IHH; GRHL2; HDAC2; SFRP2; ALX4; MKS1; INTU; B9D1;	GO:0042733~embryonic digit morphogenesis	21	55	38.1818181818182	0.00078068658325103	0.03930891547804	1	1	0.999999999999988	0.999999999999988	0.372375351296672
down	SPRY2; ONECUT2; BMP2; FGFR2; PPARG; HEY2; NR2E1; WNT5B; WNT3; WNT7B; WNT9B; WNT2B; WNT10A; WNT4; GATA5; GATA6; WNT3A; SOX2; WNT9A; WNT5A; GATA4;	GO:0045165~cell fate commitment	21	55	38.1818181818182	0.00078068658325103	0.03930891547804	1	1	0.999999999999988	0.999999999999988	0.372375351296672
down	UGT1A9; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	8	9	88.8888888888889	0.00080880322655407	0.0399273883612072	1	1	0.999999999999988	0.999999999999988	0.378234176307134
down	FGF10; RAMP2; ASS1; PENK; CRYAB; TH; GSTP1; HPGD; AREG; NQO1; GJA1; IGFBP2; BMP7; PTN; CCND1; NR2F2; GJB2; SLC6A1; ADCYAP1R1; PTGFR; MMP15; FOXA1; STXBP1; ENDOG; IHH; EZH2; BAD; RBBP8; ARNT2; WFDC1; ANXA1; GGT5;	GO:0032355~response to estradiol	32	103	31.0679611650485	0.00081156084363809	0.0399273883612072	1	1	0.999999999999988	0.999999999999988	0.378234176307134
down	APOE; ATP1B1; EDN3; DRD5; CCL1; KEL; CDH5; CHRNA7; CASR; CXCL12; CSRP3; CCL11; STC1; ANK2; CAV1; SLC10A7; GRIK2; RGN; CCL14; SYPL2; TRPM8; CCL13; CCL19; TRPV4; TMEM165; SLC24A3; STOML2; ATP13A4; ATP13A5; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	30	94	31.9148936170213	0.0008148446604328	0.0399273883612072	1	1	0.999999999999988	0.999999999999988	0.378234176307134
down	PSMD11; PSMD12; PSMD14; TP73; PSMD3; PSMD10; PSMA1; PSMA3; PSMA4; LMO1; PSMB6; PSMB5; PSMC2; YAP1; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; PUS7; PSMB7; PSMD1;	GO:1902036~regulation of hematopoietic stem cell differentiation	24	68	35.2941176470588	0.00084803771913022	0.0407337064958537	1	1	0.999999999999988	0.999999999999988	0.385872468918223
up	SH2B2; RGS14; SH2D1A; SH3BGRL; GRAP2; PTH; CD3G; GATA3; CD80; CHN2; ARHGAP4; SLA; GRAP; LDLRAP1; SKAP1; SH2D3C; HSH2D; FCRL2; ROPN1B; SH2D2A; CDC42SE2;	GO:0009967~positive regulation of signal transduction	21	67	31.3432835820896	0.00086173119505339	0.109572998951617	1	1	0.999999999574447	0.999999999574447	0.982805412026504
up	ACOD1; KCNN4; LILRA1; OR2H2; HP; CST3; HLA-B; CD74; MPO; CD48; GATA3; IL32; SP140; CEBPE; LILRA2; RNASE6; CLEC1B; CD84; CYSLTR1; IRGM; STAT5A; STAT4;	GO:0006952~defense response	22	72	30.5555555555556	0.00086923276593531	0.109572998951617	1	1	0.999999999574447	0.999999999574447	0.982805412026504
down	CCL21; LIAS; CD5L; SERPINA3; ANXA1; S100A8; S100A9; KRT16; SPP1; BMP2; MIF; DPEP1; SELE; ITGB6; SDC1; HK1; GAL; EPHA2; PRDX5; BDKRB2; AXL; FCGR2B; HRH1; XCR1; BDKRB1; CSRP3; CARD18; ELF3; TNFAIP6; MS4A2; HYAL1; IL18; SMAD1; NFE2L2; IL17A; ECM1; DAB2IP; IL34; TRIL; NLRP10; AFAP1L2; IL17RE; BLNK; SMPDL3B; IL17F; NR1H4; MGLL; CCL19; RARRES2; IL1RL2; CYP4F11; PLGRKT; NOX4; ACER3; STAB1; SPHK1; PLAA; CCL11; CXCL6; IL36A; ACKR1; CCL1; PTGFR; CXCL1; CXCL13; CCL16; CCL17; PTGER1; CCL14; GPR33; CCL26; AGTR1; CXCL9; IL36G; IL1A; IL36RN; CCL13; CCL22; CCL18; IL1F10; IL1RN; IL36B; CX3CL1; CXCL11; GGT5; CCL20; CXCL10;	GO:0006954~inflammatory response	87	381	22.8346456692913	0.00092813152001924	0.0440018716081853	1	1	0.999999999999988	0.999999999999988	0.416831962890523
up	IRGM; ACOD1; PIK3CD; NCR3; PSTPIP1; LY75; RPS6KA5; IL18RAP; LY86; KNG1; CALCA; ORM1; ITGB2; CSF1R; HCK; ADORA3; CYBA; CCL2; CCL5; FOLR2; TNFRSF1B; ITGAL; PTAFR; CD40LG; CCR7; CNR2; IL13; IL15; MAP2K3; CXCR3; AIF1; GSDMD; LOXL3; NLRP6; CXCR4; ADAM8; PRKCQ; FUT7; NFATC3; NAIP; TCIRG1; THEMIS2; NLRP9; IL27; KLRG1; CD180; P2RX7; IL22; PROK2; TLR9; ADGRE2; PYCARD; CELA1; CHST2; LY96; PF4; CD14; CCR3; PTGDR; PTGER4; PPBP; PF4V1; CCL7; RELB; C3AR1; TNFRSF4; PTGIR; FPR1; CCR5; PTGER2; FPR3; TBXA2R; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	75	381	19.6850393700787	0.001027290370191	0.125512307584992	1	1	0.999999999574447	0.999999999574447	1
up	HLA-E; HLA-G; HLA-F; HLA-C; HLA-A; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	8	12	66.6666666666667	0.00108102168817537	0.125512307584992	1	1	0.999999999574447	0.999999999574447	1
up	HLA-B; HLA-A; HLA-C; HLA-G; HLA-H; FCGRT; HLA-F; HLA-E;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	8	12	66.6666666666667	0.00108102168817537	0.125512307584992	1	1	0.999999999574447	0.999999999574447	1
down	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00111263759416169	0.0501442412035464	1	1	0.999999999999988	0.999999999999988	0.475018941799782
down	FGF10; SPRY2; SPRY1; BMP4; FGFR2; YAP1; RDH10;	GO:0060449~bud elongation involved in lung branching	7	7	100	0.00111263759416169	0.0501442412035464	1	1	0.999999999999988	0.999999999999988	0.475018941799782
down	MEIS2; PPL; SMPD2; SUN1; KCNK2; SCEL; DCN; CCNB1; FOSL1; IGFBP2; TNC; PPARG; GATA4; BDKRB1; PSPH; ENDOG; IHH; LRP11; SOST; PIEZO2; TRPV4;	GO:0009612~response to mechanical stimulus	21	57	36.8421052631579	0.00112566400136982	0.0504200789816015	1	1	0.999999999999988	0.999999999999988	0.477631967070387
down	FGF10; FLRT2; RBFOX2; FGF19; FGF1; FGF5; FGF7; FGFR2; FGFR4; FGFR3; POLR2I; POLR2H; POLR2K; RAB14; FGF12; POLR2L; GALNT3; FGFBP1; ESRP1; SPRED2; SPRED1; KLB; ESRP2; FGF22; FGF20; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	26	79	32.9113924050633	0.00122184441639839	0.053417281940866	1	1	0.999999999999988	0.999999999999988	0.506024622815037
down	MSX1; YAP1; CSNK1A1; WNT3; TGFB2; SHROOM2; PDPN; SHROOM3; SCFD1; NOX4; TFCP2L1; SHROOM4; DMRT1; CDH13; CDH17; CDH12; CDH8; CDH3; CDH24; CDH19; CDH6; CDH5; CDH1; CAP2; CYFIP1; NCKAP1; CDH11; CDH10;	GO:0000902~cell morphogenesis	28	88	31.8181818181818	0.00123771987958954	0.0536744909497849	1	1	0.999999999999988	0.999999999999988	0.508461176810182
up	RNASE2; CCL2; CCL5; SPN; TYMP; S1PR1; FPR1; FPR3; PTAFR; CX3CR1; CCR6; NCKAP1L; CCL7; C3AR1; CMTM2; CMTM5; CMTM7; CMTM3; PROK2; CYSLTR1; PTGDR2; CCR3; CXCR3; CCR10; FES; CXCR5; CXCR1; CXCR4; CCR7; CCR2; CCR5;	GO:0006935~chemotaxis	31	122	25.4098360655738	0.00124159966063953	0.140459941095938	1	1	0.999999999574447	0.999999999574447	1
down	OTC; EGFR; ASS1; REG1A; CPS1; WNT5A; FOXF1; SMO;	GO:0007494~midgut development	8	10	80	0.0012855311366694	0.0545678071443216	1	1	0.999999999999988	0.999999999999988	0.516923606457865
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; CA9; PSMB7; PSMD1; EGLN3; HIGD1A; HIF3A;	GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia	24	71	33.8028169014084	0.0013747307570442	0.05728203186957	1	1	0.999999999999988	0.999999999999988	0.542635595030206
up	A1CF; APOBEC2; APOBEC3G; APOBEC3F; APOBEC3C; AICDA; APOBEC3H; APOBEC3D;	GO:0016554~cytidine to uridine editing	8	13	61.5384615384615	0.00157090279516547	0.165019598387383	1	1	0.999999999574447	0.999999999574447	1
down	CCL22; LAMA5; BIRC5; POMC; IL1A; FN1; CXCL10; MMP1; ANXA1; CSF2; MMP3; CXCL1; CSF3; SAA1; GHR; MUC1; IL1RN; SDC1; VCAM1; EDN2; MAOA; PTPRZ1; CCND1; CNTFR; IL12A; IL12B; NOS2; CDKN1A; TEC; SOX2; CCL11; YWHAZ; CX3CL1; CCL20; LCN2; PLP2; IL18; IL13RA2; IL17A; CTF1; FSCN1; IL20RB; IL34; IL17REL; IFNL3; IL22RA1; IL17RD; IL1F10; BAD; IL22RA2; IL17F; NDN; CCL19; IL1RL2; IL1RAPL2; DUOX2; DUOX1; IL36B; IL36G; IL36RN; IL36A; IL19; IL20RA; FZD4; F3; IFNA1;	GO:0019221~cytokine-mediated signaling pathway	66	278	23.7410071942446	0.00160065084698668	0.0652868817533507	1	1	0.999999999999988	0.999999999999988	0.618465944234707
down	SOX15; NUPR1; REN; INHA; INHBA; WT1; RRM1; FSHR; HOXA11; CTNNA1; WNT5A; AKR1C3; GATA4; SOX9; STAR; WNT4; TGFB2; HMGCS1; PRDX4; ADAM15; TFAP2C; GATA6; WNT2B; SFRP2; ZFP42; SIX4; BOK; BIK;	GO:0008584~male gonad development	28	90	31.1111111111111	0.00163015468945149	0.0661208854871407	1	1	0.999999999999988	0.999999999999988	0.626366503931559
down	DIRAS3; GADD45A; CCNC; CDC25C; SFN; CDKN1A; CDKN2B; CDK7; CDK5R2; CDKN3; PKMYT1; CCND1; CCNB2; CCNF; CCNA2; CCNE1; CCNE2; CCNO; CCNB1; CCNA1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	20	55	36.3636363636364	0.00165631602138105	0.0665920151225255	1	1	0.999999999999988	0.999999999999988	0.630829538877936
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; CCNF; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; PSMB7; PSMD1; WWTR1; FBXL7; FBXW11; NCCRP1; RNF7; FBXO27; FBXO17; SKP2;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	29	95	30.5263157894737	0.00172612257604277	0.0688656881294439	1	1	0.999999999999988	0.999999999999988	0.652368158664025
down	GOT2; GOT1; PCK1; MDH2; NIT2; MDH1; MDH1B;	GO:0006107~oxaloacetate metabolic process	7	8	87.5	0.00184574497824275	0.0705538433829858	1	1	0.999999999999988	0.999999999999988	0.668360139056671
down	GJB6; GJB1; GJA1; GJB2; CTNNA1; GJA5; GJC1;	GO:0016264~gap junction assembly	7	8	87.5	0.00184574497824275	0.0705538433829858	1	1	0.999999999999988	0.999999999999988	0.668360139056671
down	CFTR; AQP1; SCNN1A; SCNN1B; SCNN1G; AQP4; TRPV4;	GO:0050891~multicellular organismal water homeostasis	7	8	87.5	0.00184574497824275	0.0705538433829858	1	1	0.999999999999988	0.999999999999988	0.668360139056671
down	AKR1C3; ALDH1A3; AKR1C1; CYP27C1; RDH10; SDR16C5; RDH13; BCO2; BCO1;	GO:0042574~retinal metabolic process	9	14	64.2857142857143	0.0019055701068792	0.0724612882829427	1	1	0.999999999999988	0.999999999999988	0.686429461399011
down	EI24; CYP27B1; SLIT3; NDUFS3; SLIT2; CRYAB; HRG; ENO1; INHBA; HSPA1B; MYL2; GJA1; WT1; MSX1; PHB; PPARG; CDKN1A; HNF4A; BDKRB1; GNG4; TGFB2; PPP2CA; HYAL1; HYAL2; ADAM15; DCUN1D3; FRZB; APBB2; RERG; SFRP2; DCBLD2; SOX17; WFDC1; NDUFA13; OSGIN1;	GO:0030308~negative regulation of cell growth	35	124	28.2258064516129	0.00191592478459268	0.0724775484575708	1	1	0.999999999999988	0.999999999999988	0.686583494858486
down	DSP; ITGB5; CTNNA1; IHH; PLEKHA7; BVES; KIFC3; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	8	11	72.7272727272727	0.00196123298207296	0.0738090824851271	1	1	0.999999999999988	0.999999999999988	0.699197184278428
down	KPNA7; CLDN5; TERT; AURKA; CLDN3; SLIT3; FGF19; HRAS; LDLR; APOE; MYCN; IGF1; PGR; ROS1; MAPT; PC; BMP2; BMP4; ACE; MIF; CCNB1; NME1; CD34; NOS2; KDR; CDKN1A; YAP1; XDH; PRKAA2; WNT4; TGFB2; NR0B2; OCLN; IQGAP3; CLDN19; CREB3L1; SFRP2; ATOH8; LGMN; SMO; CCDC3; FERMT1; OVOL2; UPK3B; GATA5; TRIM6; SLC24A3; DLL4; NDFIP2; HEY2; APLN;	GO:0010629~negative regulation of gene expression	51	204	25	0.00208689274948348	0.0776737021330486	1	1	0.999999999999988	0.999999999999988	0.735806922337131
down	KALRN; KLK8; B4GALT2; KCNK2; S100B; CCK; TH; MAPT; PTN; DRD1; ITGA3; HRH1; CHRNA7; ITGA8; KCNK10; VLDLR; GRIN2A; RIN1; ADGRF1; LGMN; SHANK3; PAK6; PLK2; PAK5; NTF3; NTF4;	GO:0007613~memory	26	83	31.3253012048193	0.00216385989777801	0.078368280387485	1	1	0.999999999999988	0.999999999999988	0.742386697392062
down	MGST3; ALOX15B; CIDEA; RDH16; CH25H; LDLR; APOC1; APOD; RBP3; PC; UGT2B7; ALOX12; IL1RN; NR2F2; PPARG; HNF4A; ALDH3B2; PITPNB; PNLIPRP1; PLTP; FABP5; HMGCS1; OCRL; SREBF2; PLA1A; GDPD4; MGLL; MGST2; APOL4; ACAT2; ANGPTL4; EPHX3; GDPD2; LIPG; HMGCLL1; NR1H4;	GO:0006629~lipid metabolic process	36	130	27.6923076923077	0.00218613856285699	0.0786256041744772	1	1	0.999999999999988	0.999999999999988	0.744824338685721
down	CLCA1; KCNK3; TERT; KCNK2; PGK1; LMNA; S100B; FABP1; P4HB; CCNB1; BMP7; CCNA2; PTN; AK4; AQP1; PCK1; CASR; STC1; NPEPPS; GNGT1; EIF4EBP1; ENDOG; PTGIS; VASN; NDNF; AQP3; GATA6; BAD; FAM162A; ERO1A; COX4I2; HILPDA;	GO:0071456~cellular response to hypoxia	32	111	28.8288288288288	0.00221469753129977	0.0792622876275472	1	1	0.999999999999988	0.999999999999988	0.750855673349079
down	CLDN5; SLC9A3R1; ALOX15B; CLDN3; SLIT2; SERPINE1; KRT16; CDH1; MIF; DPEP1; PTN; EPHA1; IGFBP5; TIE1; NKX2-1; STC1; SLURP1; AFDN; WNT4; CX3CL1; JAG1; ADAM15; DPYSL3; KANK1; PODN; SULF1; CLDN19; PTPRU; SFRP2; TBX5; LIMCH1; SRGAP1; RAP2A;	GO:0030336~negative regulation of cell migration	33	116	28.448275862069	0.00228110390492942	0.081240681023852	1	1	0.999999999999988	0.999999999999988	0.769597094398042
down	WNT9A; WNT9B; FZD7; LRP5; RARG; SDC1; WNT5A; WNT3; WNT3A; WNT4; WNT7B; FZD5; WNT2B; WNT10A; PORCN; FZD4; FZD10; PYGO1; FRZB; FZD9; SFRP2; FZD6; PLPP3;	GO:0060070~canonical Wnt signaling pathway	23	70	32.8571428571429	0.00230549626980958	0.081710816824659	1	1	0.999999999999988	0.999999999999988	0.774050714699025
down	PLPP3; AGPAT2; PLPP2; PLA2G2A; NKX2-1; PLA2G4A; PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PCSK9; CYP2W1; GATA6; PLA2G3; PLAA; PLPPR1; GDPD3; PLPPR5; PLA2G2F; PLA2G5;	GO:0006644~phospholipid metabolic process	20	57	35.0877192982456	0.00233023118721554	0.0817933552781761	1	1	0.999999999999988	0.999999999999988	0.774832605658115
down	SPRY2; FZD6; TFAP2A; FGFR2; ALDH1A3; GBX2; ITGA8; FOXG1; DLX5; DLX6; KCNQ4; WNT3A; SIX1; USH1G; TIFAB; OTOP1; CELSR1; SIX4; USH1C; MYO6;	GO:0042472~inner ear morphogenesis	20	57	35.0877192982456	0.00233023118721554	0.0817933552781761	1	1	0.999999999999988	0.999999999999988	0.774832605658115
down	JUP; DSP; DSC2; DSG2; PKP2; CTNNA3;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	6	6	100	0.0025746996404995	0.087432009652497	1	1	0.999999999999988	0.999999999999988	0.828247864714327
down	OVOL1; SNAI2; FBLN1; KDF1; FERMT1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	6	6	100	0.0025746996404995	0.087432009652497	1	1	0.999999999999988	0.999999999999988	0.828247864714327
down	GLP2R; CHRM2; GCGR; ADCY2; RXFP1; ADRA2B; GNA14; ADRA1D; GNAI3; ADRA2C; DRD1; GNA15; GNAI1; ADRA2A; DRD5; GALR3; ADRB3; GNA11; ADRA1B; GALR2; ADRA1A;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	21	62	33.8709677419355	0.00260048804445978	0.0874655476989888	1	1	0.999999999999988	0.999999999999988	0.828565572330839
down	LAMA5; LDB2; PLXNA2; UNC5C; LMNA; CEACAM1; NCK1; FUT3; LAMA1; ENPP2; LAMA3; PHLDA2; ROBO4; AJUBA; PARD6B; SRCIN1; CAMSAP3; OSGIN1; TMSB15A; PLXNB1; RHOD; RND1; RND2; AMOTL1; RND3; AMOTL2; SST;	GO:0030334~regulation of cell migration	27	89	30.3370786516854	0.00261779767641923	0.0874655476989888	1	1	0.999999999999988	0.999999999999988	0.828565572330839
down	ARHGAP10; ARHGAP32; RGS12; RGS5; ASAP2; PLXNB1; KALRN; OPHN1; BCAR3; RGS20; RGS11; ARHGEF15; RASAL1; RAPGEF3; HRAS; ERBB2; ADCYAP1; RGS4; CAV2; CCL11; AFDN; WNT4; S100A10; ARHGAP8; OCRL; ARHGEF5; RIN1; DOCK1; SEC23B; RGN; EZH2; PLEKHG6; ARHGAP29; DEPDC1; ARHGAP40; DAB2IP; ALS2CL; LLGL2; PREX2; NET1; SRGAP1; ARHGEF19; ELMOD1; ASAP3; GRHL3; AGAP11; DEPDC1B; USP6NL; AGAP3; RGPD5; CCL19; ARHGDIG; ARHGAP39; RACGAP1; HACD3; TBC1D7; ARHGAP23; ARHGAP28; RASAL2; ERRFI1; VAV3; FZD10; CCL26; CCL21; CCL18; CX3CL1; CCL20; CCL17; CCL16; CCL13; CCL14; CCL1; CCL22;	GO:0043547~positive regulation of GTPase activity	73	322	22.6708074534161	0.002623607032746	0.0874655476989888	1	1	0.999999999999988	0.999999999999988	0.828565572330839
down	EPHA1; EPHA3; EFNA5; EPHB3; EPHA5; DYNLT1; FGD1; OCRL; PTK2; ARHGEF5; NTRK2; RASIP1; DAB2IP; FGD5; TRAPPC6B; IQGAP3; PROM2; NGEF; BVES; AJUBA; VAV3; PLXNB1; PLXNA2;	GO:0043087~regulation of GTPase activity	23	71	32.3943661971831	0.00267189693291237	0.0876715419520381	1	1	0.999999999999988	0.999999999999988	0.830516966344423
down	OPLAH; GGCT; GGT5; GCLC; GSS; GGT6; CHAC2; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	9	15	60	0.0026898267904748	0.0876715419520381	1	1	0.999999999999988	0.999999999999988	0.830516966344423
down	BMP4; HOXA5; LAMA1; NKX2-1; SOX9; FOXA1; FOXF1; RSPO2; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	9	15	60	0.0026898267904748	0.0876715419520381	1	1	0.999999999999988	0.999999999999988	0.830516966344423
down	COBL; HRAS; CYFIP1; FAM98A; EPS8L1; P2RY12; EPS8L2; EPS8L3; EPS8;	GO:1900029~positive regulation of ruffle assembly	9	15	60	0.0026898267904748	0.0876715419520381	1	1	0.999999999999988	0.999999999999988	0.830516966344423
down	KRT14; KRT5; ITGB4; LAMB3; LAMC2; LAMA3; COL17A1; DST;	GO:0031581~hemidesmosome assembly	8	12	66.6666666666667	0.00288791600666272	0.0932950210824978	1	1	0.999999999999988	0.999999999999988	0.883788469545377
down	DLL1; TBX3; CCND1; YAP1; SOX9; CAV1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	7	9	77.7777777777778	0.00290406438833901	0.0934034101289124	1	1	0.999999999999988	0.999999999999988	0.884815244482933
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; PSMB7; PSMD1; FBXW11;	GO:0038061~NIK/NF-kappaB signaling	21	63	33.3333333333333	0.00303707695417155	0.0968283792244824	1	1	0.999999999999988	0.999999999999988	0.917260150546434
down	PLD2; PLA2G10; APOA4; LIPF; PLA2G2A; PLD1; PLCB4; PLCH1; LIPK; LIPM; PLCXD3; LIPI; ASPG; PLCZ1; PLCD3; ABHD4; LIPH; PLA2G12A; PLA2G2F; LDAH; PLA2G3; PLA1A; PNLIPRP3; CES3; LIPG;	GO:0016042~lipid catabolic process	25	81	30.8641975308642	0.00305871931183199	0.0970943899812408	1	1	0.999999999999988	0.999999999999988	0.919780083945562
up	MYO1G; S1PR1; ITGB7; ZAP70; GPR15; CCR6;	GO:0072678~T cell migration	6	8	75	0.00307900480978662	0.30874020956315	1	1	0.999999999574447	0.999999999574447	1
down	UBE2C; NDC80; AURKA; BIRC5; ZW10; OIP5; PRC1; BUB1; ENSA; BUB1B; CCNB2; ZWINT; PTTG1; CHEK2; CCNE2; CDK1; GNAI3; RALA; CCNB1; RCC1; CCNA2; CCNO; CCND1; CCNE1; WEE1; CDC25C; CKS2; CCNF; CETN2; CSNK1A1; CDK7; DYNLT3; NEK2; HMGA2; BCAR1; CKS1B; RAN; GNAI1; DYNLT1; CCNA1; GPSM2; CDC20; MAD2L1; PLK5; CDCA8; CENPW; FIGN; CDCA2; REEP3; LLGL2; MISP; NUP37; CABLES1; PPP1R1C; SKA1; SEH1L; SPAG5; CDCA3; KIF2C; RBBP8; TSG101; NCAPG; TUBA1C; KIFC1; PARD6G; PARD6B; NUF2; FAM83D; REEP4; ZWILCH; SPC25; ARL8B; KLHL13; FBXL7; TPX2; ANAPC7; CDC23;	GO:0051301~cell division	77	347	22.1902017291066	0.00328532162300454	0.101645167398165	1	1	0.999999999999988	0.999999999999988	0.962889829373333
down	SMIM22; FAM107A; HRG; EZR; EPHA3; EFNA5; EPHA5; ARHGEF5; GPM6B; FSCN1; ARHGEF19; GRHL3; CELSR1; VANGL2; FZD10; BAIAP2; ARHGAP40; RHOJ; RND3; RND2; RND1; ARHGAP28; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	24	77	31.1688311688312	0.00329953495046775	0.101645167398165	1	1	0.999999999999988	0.999999999999988	0.962889829373333
down	MGST3; GSTZ1; APOE; S100A9; FABP1; GSTA1; GSTP1; TXN; MGST1; GPX2; GPX3; PRDX5; PRDX3; PRDX4; NXN; IYD; TXNRD3; GPX8; CYGB; MGST2; TXNDC17; GSTO2; DUOX2; DUOX1;	GO:0098869~cellular oxidant detoxification	24	77	31.1688311688312	0.00329953495046775	0.101645167398165	1	1	0.999999999999988	0.999999999999988	0.962889829373333
down	PLPP3; LAMA5; ADAM11; APOA1; CEACAM1; ITGA2; ITGB5; PTN; NME2; FBLN1; ITGA3; TEC; ITGA8; BCAR1; DST; PTK2; COL16A1; CDH17; ADAM9; ADAM15; DOCK1; FERMT2; FERMT1; VAV3; ITGBL1; ITGB6; ITGB4; LAMA3;	GO:0007229~integrin-mediated signaling pathway	28	96	29.1666666666667	0.00350915011850272	0.107197928933843	1	1	0.999999999999988	0.999999999999988	1
down	MYO1C; CLDN1; ASS1; GAPDH; GSN; MRC1; IL12B; NOS2; WNT5A; STAR; AQP4; STXBP1; VAMP3; GBP6; RAB7B; CCL21; CCL20; CCL1; CCL13; CCL16; CX3CL1; CCL17; CCL22; CCL14; CCL19; CCL11; CCL18; CCL26;	GO:0071346~cellular response to interferon-gamma	28	96	29.1666666666667	0.00350915011850272	0.107197928933843	1	1	0.999999999999988	0.999999999999988	1
down	IDH1; GOT2; DLD; GOT1; KYAT3; AADAT; GPT2; L2HGDH; MRPS36;	GO:0006103~2-oxoglutarate metabolic process	9	16	56.25	0.00370878320166512	0.111588405571562	1	1	0.999999999999988	0.999999999999988	1
down	EDN3; EDN2; KEL; EDNRB; EDNRA; HTR1D; BDKRB2; CAV1; TRPM4;	GO:0042310~vasoconstriction	9	16	56.25	0.00370878320166512	0.111588405571562	1	1	0.999999999999988	0.999999999999988	1
up	FFAR1; S1PR4; KNG1; OXT; CALCA; CD36; GATA2; CD52; GLP1R; IL2; PROK2; GPR35; GHRL; TRPC5; CYSLTR1; PTGER4; PTGDR; CCR10; TBXA2R; FPR3; CXCR4; CXCR3; CCR7; PTGER2; CCR6; CCR5; FPR1; CXCR5; PTGIR; CCR2; CCR3; C3AR1; CXCR1; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	34	150	22.6666666666667	0.00371152161076216	0.361024214602971	1	1	0.999999999574447	0.999999999574447	1
down	SNAI2; PENK; BMP2; BMP4; IGFBP5; TNC; EPHA2; PHB; MSX2; PSMC2; ID4; SOX2; HSD17B4; DLX5; WNT3A; HSPE1; CYP24A1; FHL2; IHH; GPNMB; FIGNL1; RSPO2; TP53INP2; CCDC47; CREB3L1; SMO; LGR4; WWTR1; BCAP29; SPP1;	GO:0001649~osteoblast differentiation	30	106	28.3018867924528	0.00372823352447527	0.111588405571562	1	1	0.999999999999988	0.999999999999988	1
down	LRP5; IGF1; GLI3; BMP2; BMP4; BMP7; NPPC; MSX2; WNT4; WNT7B; JAG1; SMAD1; FFAR4; NPNT; NELL1; SFRP2; TP63; ZHX3; GDPD2; CTNNBIP1;	GO:0045669~positive regulation of osteoblast differentiation	20	60	33.3333333333333	0.00376379390095749	0.11170511898736	1	1	0.999999999999988	0.999999999999988	1
down	NKX2-8; NUPR1; BMP4; KRT4; PTN; WNT5A; CDKN2B; SOX2; SOX9; RIDA; ISL1; TGFB2; DLG1; RGN; DAB2IP; MARVELD3; SFRP2; WFDC1; A4GNT; STRAP;	GO:0050680~negative regulation of epithelial cell proliferation	20	60	33.3333333333333	0.00376379390095749	0.11170511898736	1	1	0.999999999999988	0.999999999999988	1
up	APOBEC3H; APOBEC3F; APOBEC3D; AICDA; APOBEC3G; APOBEC3C; APOBEC2;	GO:0009972~cytidine deamination	7	12	58.3333333333333	0.00384590618457381	0.361024214602971	1	1	0.999999999574447	0.999999999574447	1
up	IL2RA; LYN; CTLA4; HLA-G; PDCD1; FCRLB; INPP5D;	GO:0050777~negative regulation of immune response	7	12	58.3333333333333	0.00384590618457381	0.361024214602971	1	1	0.999999999574447	0.999999999574447	1
down	FOXH1; BMP4; GATA4; ISL1; TGFB2; JAG1; PPP1R13L; HEY2;	GO:0003215~cardiac right ventricle morphogenesis	8	13	61.5384615384615	0.00412278429905311	0.117579875653854	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; AREG; MDK; FGF7; CDH3; TGM1; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	8	13	61.5384615384615	0.00412278429905311	0.117579875653854	1	1	0.999999999999988	0.999999999999988	1
down	GABRA1; GABRB2; GABRG3; GABRA5; GABRA4; GABRA3; GABRA2; GABRE;	GO:0051932~synaptic transmission, GABAergic	8	13	61.5384615384615	0.00412278429905311	0.117579875653854	1	1	0.999999999999988	0.999999999999988	1
down	E2F8; CYP1A1; ITGA2; CPS1; HNF1B; HNF4A; PCK1; ANXA1;	GO:0070365~hepatocyte differentiation	8	13	61.5384615384615	0.00412278429905311	0.117579875653854	1	1	0.999999999999988	0.999999999999988	1
up	IRGM; ACOD1; CD14; VIM; CCL2; CD36; TNFRSF1B; TBXA2R; IL10; CASP1; CX3CR1; CCR5; HAMP; IRF8; MEF2C; CEBPE; CARD16; LILRB2; LILRB1; NLRP7; GFI1; LITAF; AICDA; STAP1; PYCARD; DEFA4; PF4; PF4V1; LY96; CD80; NR1H2; CD86; NR1I2; DEFA3; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	36	163	22.0858895705521	0.00414991281665411	0.373661537695468	1	1	0.999999999574447	0.999999999574447	1
down	MVD; DHDDS; DOLPP1; SRD5A3; DOLK; DPAGT1;	GO:0006489~dolichyl diphosphate biosynthetic process	6	7	85.7142857142857	0.00424244993670442	0.119591223891425	1	1	0.999999999999988	0.999999999999988	1
down	HOXD10; ISL1; ISL2; HOXC10; LHX3; MNX1;	GO:0021520~spinal cord motor neuron cell fate specification	6	7	85.7142857142857	0.00424244993670442	0.119591223891425	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; HOXC11; SPRY1; FGF1; HOXA11; GDNF; SIX1;	GO:0001759~organ induction	7	10	70	0.00437074720156505	0.121308541339318	1	1	0.999999999999988	0.999999999999988	1
down	SPRY2; HRG; DCN; IL12A; IL12B; XDH; DAB2IP;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	7	10	70	0.00437074720156505	0.121308541339318	1	1	0.999999999999988	0.999999999999988	1
down	CCL22; CXCL11; DEFB4A; CCL16; PIK3C2G; CXCL14; PLAU; HRAS; CXCL10; HRG; CXCL1; RALA; FOSL1; CCL1; CXCL12; CCL11; CCL18; DEFB1; CX3CL1; CCL20; CXCL6; PLP2; CXCL9; PLD1; ENPP2; ECSCR; CCL17; CCL13; RARRES2; PLGRKT; CCL26; ACKR3; XCR1;	GO:0006935~chemotaxis	33	122	27.0491803278689	0.00438644773504726	0.121308541339318	1	1	0.999999999999988	0.999999999999988	1
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; ITGB5; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; VAMP3; PSMD5; PSMB7; PSMD1; CD207;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	23	75	30.6666666666667	0.00466643180153514	0.127601567726622	1	1	0.999999999999988	0.999999999999988	1
up	OR2A1; OR5K3; OR5B21; OR1F1; OR7C1; OR6A2; OR2H2; OR4E1; OR2T7; OR1E1; OR3A1; OR3A4P; OR3A3; OR3A2; OR2B6; OR4D2; OR4D1; OR2B11; OR2G6; OR2T2; OR2W3; OR6V1; OR2L13; OR2C3; OR2L5; OR2AK2; OR2L3; OR5AU1; OR4E2; OR10G2; OR6J1; OR11H7; OR10AD1; OR52B6; OR2D3; OR56A4; OR52N2; OR56B2P; OR52N4; OR56B1; OR52H1; OR52K1; OR52I1; OR1L4; OR1L8; OR1J1; OR9A1P; OR9A4; OR2T34; OR2L8; OR2T10; OR2T11; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR51Q1; OR52I2; OR1L3; OR1F12; OR5K1; OR5K2; OR5B12; OR5B2; OR1F2P; OR2B2; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; OR51M1; OR51J1; OR51I1; OR51I2; OR1A1; OR1A2; OR51B4;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	79	435	18.1609195402299	0.0049636815866182	0.424092426357298	1	1	0.999999999574447	0.999999999574447	1
down	GCAT; DDC; GGT5; GSS; ACY1; PTS; KYAT3; BPHL; PHGDH;	GO:0006520~cellular amino acid metabolic process	9	17	52.9411764705882	0.00500671494203642	0.135888571716758	1	1	0.999999999999988	0.999999999999988	1
down	PLXNB1; KLK8; EGFR; GJA1; BMP7; WEE1; NBL1; WNT7B; DYNLT1; CTTN; UGT8; DAB2IP; NYAP1; NTF3; NRK; STK3; MNX1; DCLK1; NTF4; NCKAP1;	GO:0048812~neuron projection morphogenesis	20	62	32.258064516129	0.00507759700836674	0.137301984289206	1	1	0.999999999999988	0.999999999999988	1
up	NCR3; SH2D1A; IL18RAP; CRTAM; CD160; HLA-E; LAG3; SLAMF6; IL21;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	9	21	42.8571428571429	0.00529821730107682	0.424092426357298	1	1	0.999999999574447	0.999999999574447	1
down	FZD9; SUN1; EGFR; STATH; CLEC3B; MGP; BMP7; BMP5; NPPC; CASR; SOX9; STC1; CDH11; GPM6B; ECM1; RIPPLY2; KAZALD1; SORT1; FOXC2; SOST; CHRDL1; ATP6V0A4; TNFRSF11A;	GO:0001503~ossification	23	76	30.2631578947368	0.00532333588637701	0.142888512156024	1	1	0.999999999999988	0.999999999999988	1
up	CD74; CD19; CD27; TCIRG1; INPP5D; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	7	13	53.8461538461538	0.00533469014415755	0.424092426357298	1	1	0.999999999574447	0.999999999574447	1
up	PSMB11; TAPBP; HLA-B; HLA-H; HLA-A; HLA-C; CYBA; HLA-E; CD36; HLA-G; PSMB8; PSMB9; HLA-F; PSMB10; PSMB3; B2M; PSME1; NCF4; PSMA8; PSMF1;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	20	75	26.6666666666667	0.00538324303459103	0.424092426357298	1	1	0.999999999574447	0.999999999574447	1
up	CCL5; CXCR1; CCR7; GPR183; CCR2; CCR5; CCR6; CXCR4;	GO:0002407~dendritic cell chemotaxis	8	17	47.0588235294118	0.00547898193616636	0.424092426357298	1	1	0.999999999574447	0.999999999574447	1
down	SNAI2; FGFR2; SFN; EFNB2; SLURP1; CD109; KDF1; INTU;	GO:0010839~negative regulation of keratinocyte proliferation	8	14	57.1428571428571	0.005727188269254	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	LDLR; APOE; ACADL; EPHX2; ACADVL; SERPINA12; NR1H4; ARV1;	GO:0090181~regulation of cholesterol metabolic process	8	14	57.1428571428571	0.005727188269254	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	COBL; BMP7; PTN; BMP5; VLDLR; EZH2; DAB2IP; CYFIP1;	GO:1900006~positive regulation of dendrite development	8	14	57.1428571428571	0.005727188269254	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	EFNA2; KALRN; HRAS; YES1; NCK1; EFNA1; EPHA1; EPHA2; EPHA3; EPHA8; PSEN2; EFNA3; EFNB2; EFNA5; EPHB3; EPHA5; EFNB1; PTK2; EFNB3; EPHA10; ARHGEF28; NGEF; ARPC1A; EPHA6; VAV3;	GO:0048013~ephrin receptor signaling pathway	25	86	29.0697674418605	0.00578063941708296	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	PSMD11; PSMD12; TNFRSF11B; PSMD14; PSMD3; PSMD10; KRT18; KRT8; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; TNFSF9; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; EDARADD; PYDC1; PSMB7; PSMD1; TXNDC17; PLVAP; CARD14; TNFRSF19; TNFSF18; TNFRSF11A;	GO:0033209~tumor necrosis factor-mediated signaling pathway	32	120	26.6666666666667	0.00590877381864297	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	PODXL; ATP8B1; PLD1; KLF5; FSCN1;	GO:0032534~regulation of microvillus assembly	5	5	100	0.00602841191112569	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	NFIB; FGF10; NKX2-1; AIMP2; GATA6;	GO:0060510~type II pneumocyte differentiation	5	5	100	0.00602841191112569	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	HPGD; FOXF1; MYOCD; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	5	5	100	0.00602841191112569	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	TXNDC9; TXNL1; GLRX3; P4HB; DLD; TXN; NQO1; NOS1; NOS2; GCLC; PDIA6; NFE2L2; TXNDC8; NXN; TXNRD3; ERO1A; TMX1; PTGES2; TMX2; PRDX4; PRDX3; PRDX1; PRDX5;	GO:0045454~cell redox homeostasis	23	77	29.8701298701299	0.00605494815864172	0.149854835614384	1	1	0.999999999999988	0.999999999999988	1
down	KCNK1; KCNK3; KCNK5; AQP1; GJA5; NSF; KCNJ4; KCNJ5; KCNJ3; ATP1A2; KCNQ4; FXYD3; KCNJ8; KCNV1; KCNB2; KCNS3; KCNN2; KCNF1; KCNJ16; KCNK6; KCNK7;	GO:0006813~potassium ion transport	21	68	30.8823529411765	0.00624444903596277	0.151623015181715	1	1	0.999999999999988	0.999999999999988	1
down	IRF6; KLK8; FST; KRT2; CDH13; SDR16C5; FERMT1;	GO:0043616~keratinocyte proliferation	7	11	63.6363636363636	0.00633406651560375	0.151623015181715	1	1	0.999999999999988	0.999999999999988	1
down	INHBA; ITGB4; ITGA2; FGFR2; ITGA3; HMGA2; ITGA8;	GO:0048333~mesodermal cell differentiation	7	11	63.6363636363636	0.00633406651560375	0.151623015181715	1	1	0.999999999999988	0.999999999999988	1
down	INHBA; FSHR; EPHA8; GCLC; STAR; EFNA5; HMGCS1;	GO:0071372~cellular response to follicle-stimulating hormone stimulus	7	11	63.6363636363636	0.00633406651560375	0.151623015181715	1	1	0.999999999999988	0.999999999999988	1
down	CTNND1; EFNB2; YWHAE; EPS8; CPT1C; DLG3; PORCN;	GO:0099072~regulation of postsynaptic membrane neurotransmitter receptor levels	7	11	63.6363636363636	0.00633406651560375	0.151623015181715	1	1	0.999999999999988	0.999999999999988	1
down	WNT5A; AFDN; FOXA1; WNT3A; TJP1; PTPRU; FOXA2;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	7	11	63.6363636363636	0.00633406651560375	0.151623015181715	1	1	0.999999999999988	0.999999999999988	1
down	CLDN1; EGFR; LDLR; CDK1; CTSB; HSPA1B; IDE; ITGA2; ITGB5; ITGB6; MRC1; EPHA2; SERPINB3; AXL; EFNB2; DYNLT1; CXADR; TYRO3; HYAL1; HYAL2; EFNB3; NECTIN4; ACE2; SLC52A1; LAMP3;	GO:0046718~viral entry into host cell	25	87	28.735632183908	0.00651475381706756	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
down	SULT2B1; MBTPS2; LRP5; ERLIN1; LDLR; APOA1; APOE; APOC1; CYP11A1; APOA4; CYP2C9; FDXR; STAR; VLDLR; SREBF2; EBP; NR0B2; PCSK9; OSBPL1A; NSDHL; CH25H; SQLE;	GO:0008203~cholesterol metabolic process	22	73	30.1369863013699	0.00657814192385031	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
down	LIPF; FH; MDH2; ME1; MDH1; MDH1B;	GO:0006108~malate metabolic process	6	8	75	0.0065898091935841	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
down	HOXB1; NKX2-1; LHX1; FOXA1; DLX6; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	6	8	75	0.0065898091935841	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; BMP7; FGFR2; HMGA2; ISL1; WWTR1;	GO:0048762~mesenchymal cell differentiation	6	8	75	0.0065898091935841	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
down	RBP4; BMP7; BMP5; GJC1; CSRP3; TBX2; GATA4; SGCD; GATA5;	GO:0048738~cardiac muscle tissue development	9	18	50	0.00663060602264909	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
down	HOXB7; GDNF; SOX9; LHX1; SIX1; WNT2B; SMO; LGR4; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	9	18	50	0.00663060602264909	0.15466471109061	1	1	0.999999999999988	0.999999999999988	1
up	HLA-E; HLA-G; HLA-F; CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	6	10	60	0.00670019060767124	0.509676568293888	1	1	0.999999999574447	0.999999999574447	1
down	TRAPPC3; SEC31A; CNIH1; TGFA; CD59; FOLR1; AREG; GRIA1; NSF; TMED10; RAB1A; COL7A1; TMED2; TRAPPC6B; MCFD2; SCFD1; TFG; SEC16B; GORASP1; SAR1B;	GO:0048208~COPII vesicle coating	20	64	31.25	0.0067473882604554	0.15688752130441	1	1	0.999999999999988	0.999999999999988	1
down	SPINT1; SPINT2; LIAS; FZD6; COBL; TULP3; RALA; MTHFD1; BMP4; RARG; SDC4; LHX2; TGFB2; TMED2; ALX1; GRHL2; GRHL3; SHROOM3; GLMN; MKS1; CELSR1; VANGL2; ST14;	GO:0001843~neural tube closure	23	78	29.4871794871795	0.0068674417970942	0.157670416857185	1	1	0.999999999999988	0.999999999999988	1
down	PLA2G10; LRP5; LDLR; APOA1; APOE; APOC3; APOA4; FABP4; FGFR4; CD24; EPHX2; HNF4A; CAV1; AKR1C1; SREBF2; MALL; IL18; TMEM97; MALRD1; GPIHBP1; PCSK9; LIPG; NR1H4; CYP39A1;	GO:0042632~cholesterol homeostasis	24	83	28.9156626506024	0.00711511351448613	0.162844651314305	1	1	0.999999999999988	0.999999999999988	1
down	EGFR; ERBB2; MET; PDGFRA; EPHA1; FGFR2; ERBB3; FGFR4; FGFR3; EPHA2; EPHA3; EPHA8; WEE1; AXL; TTK; TIE1; FLT4; KDR; TEC; EPHB3; EPHA5; ROR1; TEK; MST1R; PTK2; TYRO3; TWF1; EFEMP1; MELK; NTRK2; EPHA10; STYK1; EPHA6;	GO:0018108~peptidyl-tyrosine phosphorylation	33	127	25.9842519685039	0.0072220850464344	0.163245953325132	1	1	0.999999999999988	0.999999999999988	1
down	SLIT2; BMP4; TGFB2; JAG1; STRA6; ROBO2; HEYL; HEY2;	GO:0003184~pulmonary valve morphogenesis	8	15	53.3333333333333	0.00776538462250642	0.169745727930896	1	1	0.999999999999988	0.999999999999988	1
down	PODXL; SPINT2; CDH1; JAG1; PTK2; B4GALNT2; EPB41L5; MUC21;	GO:0022408~negative regulation of cell-cell adhesion	8	15	53.3333333333333	0.00776538462250642	0.169745727930896	1	1	0.999999999999988	0.999999999999988	1
down	SERPINA3; RBP4; MUC2; MUC4; MUC13; STRAP; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	8	15	53.3333333333333	0.00776538462250642	0.169745727930896	1	1	0.999999999999988	0.999999999999988	1
down	ACOX3; SCP2; HSD17B4; EHHADH; ACOX2; DECR2; AMACR; CROT;	GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase	8	15	53.3333333333333	0.00776538462250642	0.169745727930896	1	1	0.999999999999988	0.999999999999988	1
down	PGR; TACSTD2; EDNRB; SERPINB5; HES1; SIX1; HES5; SIX4;	GO:0050678~regulation of epithelial cell proliferation	8	15	53.3333333333333	0.00776538462250642	0.169745727930896	1	1	0.999999999999988	0.999999999999988	1
down	AURKA; ENSA; CCNB2; CHEK2; CDK1; CCNB1; CCNA2; TUBG1; WEE1; CDC25C; CDKN1A; CETN2; CDKN2B; NES; CDK7; NEK2; PLK1; YWHAE; DYNLL1; TUBB4B; FOXM1; DCTN2; MELK; TPD52L1; CEP70; CEP76; PHLDA1; AJUBA; PKMYT1; FBXL7; FBXW11; NINL; USH1C; SKP2;	GO:0000086~G2/M transition of mitotic cell cycle	34	133	25.5639097744361	0.00792372102803274	0.172029373143839	1	1	0.999999999999988	0.999999999999988	1
down	MATN3; SLC34A2; TSPAN15; PENK; APOA1; APOE; FN1; AFP; TF; MMP1; IGF1; GSN; APOA4; P4HB; PGA3; PGA5; SAA1; SPP1; BMP4; IGFBP2; HRC; IGFBP6; IGFBP5; TNC; ADORA2B; MMP13; LAMB2; CKAP4; MSLN; SPARCL1; PDIA6; TMEM132A; NOTUM; VWA1; AMTN; HIST2H3A; SFTPA2; BPIFB2; PCSK9; GATA6; CHRDL1; PAPPA2; EVA1A; L2HGDH; LMCD1; DMBT1; SERPINA10;	GO:0044267~cellular protein metabolic process	47	200	23.5	0.00794054222017171	0.172029373143839	1	1	0.999999999999988	0.999999999999988	1
up	LPXN; GPS2; FCRL3; CD300A; PLCL2;	GO:0050859~negative regulation of B cell receptor signaling pathway	5	7	71.4285714285714	0.00798826529542218	0.587403774723378	1	1	0.999999999574447	0.999999999574447	1
up	HLA-DRA; HLA-DRB1; HLA-DMA; HLA-DMB;	GO:0002503~peptide antigen assembly with MHC class II protein complex	4	4	100	0.00840118881173335	0.607640082579796	1	1	0.999999999574447	0.999999999574447	1
down	DLX2; DLX3; DLX5; DLG1; DLX1; DLX6; DLG2; DLG3; LRRC1;	GO:0009790~embryo development	9	19	47.3684210526316	0.00862941044218213	0.184220250404596	1	1	0.999999999999988	0.999999999999988	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G12A; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	9	19	47.3684210526316	0.00862941044218213	0.184220250404596	1	1	0.999999999999988	0.999999999999988	1
down	GPR37; FGF10; ALOX12B; BCAR3; HRAS; IGF1; ADRA2A; BMP2; ADRB3; ADRA2B; ADRA2C; EFNA1; FGFR2; FGFR3; EPHA8; ADRA1A; ADRA1B; FLT4; KDR; THPO; SOX2; CAV2; CX3CL1; NTRK2; DAB2IP; WWC1; ROR1; TEK; ERBB2;	GO:0043410~positive regulation of MAPK cascade	29	109	26.605504587156	0.00867513797305719	0.184656508283646	1	1	0.999999999999988	0.999999999999988	1
down	ADRA2A; CHRNB4; ATP1A2; CNN1; CAV1; KCNB2; CHRM2;	GO:0006940~regulation of smooth muscle contraction	7	12	58.3333333333333	0.00888488607685267	0.185767602028295	1	1	0.999999999999988	0.999999999999988	1
down	C1QL1; FARP2; C1QA; EPHA8; CX3CL1; RND1; NTN4;	GO:0016322~neuron remodeling	7	12	58.3333333333333	0.00888488607685267	0.185767602028295	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; TULP3; RARG; ALDH1A3; NES; RDH10; PPP1R13L;	GO:0031076~embryonic camera-type eye development	7	12	58.3333333333333	0.00888488607685267	0.185767602028295	1	1	0.999999999999988	0.999999999999988	1
down	PLPP3; RER1; ZW10; KIF1C; ARF4; RAB6A; KDELR2; COPB2; NSF; PITPNB; TMED10; RAB1A; TMED2; RINT1; SCFD1; KIF2C; RACGAP1; COG4; PICK1; TMED7; TMED3; RAB6C; DNAJC28; GOLPH3L;	GO:0006890~retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum	24	85	28.2352941176471	0.0089984106464136	0.185767602028295	1	1	0.999999999999988	0.999999999999988	1
up	PGLYRP1; HLA-B; HLA-DRB1; HLA-A; CD1D; PGLYRP2;	GO:0016045~detection of bacterium	6	11	54.5454545454545	0.0093581237798821	0.645125658075622	1	1	0.999999999574447	0.999999999574447	1
up	RHO; SAG; GNAT1; PDE6G; PDE6B; GRK1;	GO:0016056~rhodopsin mediated signaling pathway	6	11	54.5454545454545	0.0093581237798821	0.645125658075622	1	1	0.999999999574447	0.999999999574447	1
up	APOBEC3H; APOBEC3F; APOBEC3D; APOBEC3G; APOBEC3C; AICDA;	GO:0070383~DNA cytosine deamination	6	11	54.5454545454545	0.0093581237798821	0.645125658075622	1	1	0.999999999574447	0.999999999574447	1
down	PANO1; FZD9; DFFA; PDCD5; UNC13B; MCF2L; EEF1E1; KALRN; SLIT2; PLEKHG5; UNC5C; SPDEF; LDHA; HRG; S100B; NGFR; TGFB3; TOP2A; BMP2; BMP4; RARG; FOSL1; HPGD; BMP7; HOXA5; PTN; GAL; GADD45A; ALDH1A3; PSEN2; HMGA2; FOXA1; FOXL2; MAP3K9; FGD1; EEF1A2; C1QBP; ARHGEF5; GRIN2A; STK3; MELK; PLEKHN1; PHLDA2; STPG1; ARHGEF16; DAB2IP; TCTN3; NET1; ARHGEF19; DCUN1D3; NGEF; FANK1; CSRNP3; FRZB; APBB2; BAD; FAM162A; ARHGEF26; SFRP2; AIFM2; NOX4; ARHGEF4; OSGIN1; VAV3; BOK; FAF1; UTP11; PHLDA3; SCIN; MTCH2; PHLDA1;	GO:0043065~positive regulation of apoptotic process	71	332	21.3855421686747	0.00937830491108871	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
up	TESPA1; RAB29; KCNN4; ADA; LCK; CCR7; TRAT1;	GO:0050862~positive regulation of T cell receptor signaling pathway	7	15	46.6666666666667	0.00954780636315955	0.647230952952746	1	1	0.999999999574447	0.999999999574447	1
down	PITX3; GJB6; CLDN1; ASS1; PENK; KRT14; C1QA; HMGCR; CYP1A1; APOD; EIF2S1; GSN; DCN; COL4A2; KRT16; MMP7; CNP; DLD; TGFB3; NQO1; ALOX12; IGFBP2; EDNRB; IGFBP5; GJB2; ALDH3A1; CTNNA1; ADRA1A; PCK1; GCLC; GSS; FOXG1; CX3CL1; ENDOG; KRT33B; RGN; NFE2L2; AURKB; KRTAP4-8; SRR;	GO:0007568~aging	40	166	24.0963855421687	0.00966687267256516	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
up	PSMB11; TNFRSF13B; TNFSF12; TNFSF14; TNFSF13; LTA; TNFRSF1B; CD27; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; TNFSF8; PSMB10; TNFRSF4; PSMB3; TNFRSF17; PSME1; LTB; TRADD; COMMD7; PSMA8; PSMF1; TNFRSF14; PYCARD; TNFSF13B;	GO:0033209~tumor necrosis factor-mediated signaling pathway	27	120	22.5	0.00968205867971017	0.647230952952746	1	1	0.999999999574447	0.999999999574447	1
down	AKR7A3; AKR1A1; ALDH3A1; ALDH9A1; ALDH7A1; ALDH3A2;	GO:0006081~cellular aldehyde metabolic process	6	9	66.6666666666667	0.0097525186704992	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	PLA2G4A; CYP2J2; CYP4F2; PTGIS; CYP4F22; CYP2S1;	GO:0006690~icosanoid metabolic process	6	9	66.6666666666667	0.0097525186704992	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	NME2; AK4; CMPK1; AK7; AK8; SUCLG1;	GO:0009142~nucleoside triphosphate biosynthetic process	6	9	66.6666666666667	0.0097525186704992	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	RARG; ALDH1A3; MFAP2; FOXL2; EFEMP1; VAX2;	GO:0048048~embryonic eye morphogenesis	6	9	66.6666666666667	0.0097525186704992	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	CD34; NES; WNT3; WNT7B; RNF43; ZNRF3;	GO:0072089~stem cell proliferation	6	9	66.6666666666667	0.0097525186704992	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	DSP; DSG2; GRHL1; PKP2; PERP;	GO:0002934~desmosome organization	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	GJA1; CD34; GJA4; KDR; GJA5;	GO:0003158~endothelium development	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	TCF21; ID1; FOXF1; STRA6; ERRFI1;	GO:0060426~lung vasculature development	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	PDHX; PDHA1; DLD; PDHB; MPC1;	GO:0061732~mitochondrial acetyl-CoA biosynthetic process from pyruvate	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	CACNA1G; GJA5; ANK2; SCN5A; HCN4;	GO:0086015~SA node cell action potential	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	GJB6; GJB2; MIP; GJB4; GJA3;	GO:1990349~gap junction-mediated intercellular transport	5	6	83.3333333333333	0.00984249382344649	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	MAPK13; PCK1; SOX9; LCN2; HYAL1; HYAL2; IL17A; PTGIS; DAB2IP; HAS2; CCL16; CCL17; CCL13; CCL14; CCL21; CCL22; CCL26; CCL20; CX3CL1; CCL11; CCL18; CCL1; CCL19;	GO:0071347~cellular response to interleukin-1	23	81	28.3950617283951	0.00985566104173874	0.188861368151534	1	1	0.999999999999988	0.999999999999988	1
down	WNT9B; TBX3; LMX1B; GJB3; CCNB2; SLC34A2; GLI2; GLI3; TGFB3; BMP2; CCNB1; FOSL1; PDGFRA; FGFR2; CPT2; EDNRA; MSX1; TIE1; SOX18; HSD17B2; WNT3A; WNT7B; PSPH; OCRL; FOXF1; FOXC1; MYO1E; KEAP1; ENDOG; DSC3; IHH; PTPRR; ANGPT1; NXN; RDH10; GATA6; SMO; ARNT2; EPB41L5; TMEM100; ETNK2; CAMSAP3; FOXD3; MAFF; B9D1; JAG2; RTCB;	GO:0001701~in utero embryonic development	47	203	23.1527093596059	0.00989389520942219	0.189097719696313	1	1	0.999999999999988	0.999999999999988	1
down	SLC9A3R1; SPRY2; SPRY1; PSCA; GSTP1; EZR; FBLN1; PHB; DLG1; PTPRR; DAB2IP; CNKSR3; SPRED1; CAMK2N1; C1QL4; SPRY4; ERRFI1; RPS6KA6; NDRG2; WNK2;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	20	67	29.8507462686567	0.0100661028223399	0.191886727691654	1	1	0.999999999999988	0.999999999999988	1
down	CLDN3; RAB25; FAT1; IHH; DACT2; GRHL2; POF1B; PALLD;	GO:0003382~epithelial cell morphogenesis	8	16	50	0.0103031635385248	0.192880505114793	1	1	0.999999999999988	0.999999999999988	1
down	MGST3; TP73; CYP2E1; MGST1; CCND1; CDKN1A; FUNDC1; MGST2;	GO:0010243~response to organonitrogen compound	8	16	50	0.0103031635385248	0.192880505114793	1	1	0.999999999999988	0.999999999999988	1
down	ADRA2A; ACE; EDN3; EDN2; BDKRB2; AGTR1; ATP1A2; ACE2;	GO:0019229~regulation of vasoconstriction	8	16	50	0.0103031635385248	0.192880505114793	1	1	0.999999999999988	0.999999999999988	1
down	ALOX15B; ALOX12B; HPGD; ALOX12; PON2; PON3; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	8	16	50	0.0103031635385248	0.192880505114793	1	1	0.999999999999988	0.999999999999988	1
down	SYT7; DOC2B; RIMS2; RIMS1; SYT8; SYT10; RIMS4; SYT12;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	8	16	50	0.0103031635385248	0.192880505114793	1	1	0.999999999999988	0.999999999999988	1
down	CLDN3; HMGCR; SERPINE1; GJA1; WNT4; CD109; CLDN19; WFDC1;	GO:0061045~negative regulation of wound healing	8	16	50	0.0103031635385248	0.192880505114793	1	1	0.999999999999988	0.999999999999988	1
down	PPFIA2; ITGB4; ITGA2; ITGB5; VCAM1; ITGA3; HOXD3; BCAM; ITGA8; EMP2; ADAM9; ADAM15; NPNT; FERMT2; MUC4; SORBS1; COL17A1; LYVE1; LYPD5; CD34; ITGB6; MSLN; MSLNL; ITGBL1; LYPD3; COL16A1;	GO:0007160~cell-matrix adhesion	26	96	27.0833333333333	0.0103954111911806	0.194109711270613	1	1	0.999999999999988	0.999999999999988	1
down	RAB5A; RAB1A; RAB38; RAB22A; RAB25; RAB11A; RAB40AL; RAB3B; RAB26; RAB17; RAB9A; RAB6A; RAB6C; RAB7B; RAB3C; IFT22; RAB14; RAB2A; RAB13; RAB18; RAB10;	GO:0032482~Rab protein signal transduction	21	72	29.1666666666667	0.0104634699122915	0.19488212711643	1	1	0.999999999999988	0.999999999999988	1
down	EDN3; EDN2; HRC; AVPR1A; SLC1A1; NMU; RGS4; TRPM4; HEY2;	GO:0010460~positive regulation of heart rate	9	20	45	0.0110532318612558	0.203273667050451	1	1	0.999999999999988	0.999999999999988	1
down	SYNGR1; TMED10; RAB10; ABCA12; RIMS1; STEAP2; TMEM79; RAB11FIP5; RAB26;	GO:0045055~regulated exocytosis	9	20	45	0.0110532318612558	0.203273667050451	1	1	0.999999999999988	0.999999999999988	1
down	ETV2; FOXN1; COL4A1; NR2F2; FLT4; ID1; SLC1A1; EFNB2; LAMA1;	GO:0048514~blood vessel morphogenesis	9	20	45	0.0110532318612558	0.203273667050451	1	1	0.999999999999988	0.999999999999988	1
down	NOS1AP; LYPLA1; DDAH1; EGFR; SPR; CAV1; NOSTRIN; ZDHHC21; CYGB;	GO:0050999~regulation of nitric-oxide synthase activity	9	20	45	0.0110532318612558	0.203273667050451	1	1	0.999999999999988	0.999999999999988	1
down	NFIB; UPK1B; LRAT; LY6G6C; TF; CYP2E1; BMP2; FABP4; PRLR; FCGR2B; NOS2; ADH7; DEFB1; CAV1; SLC10A2; FER1L6; NAALADL2; GKN2; HERC6; MT1M; STOX2; ADAMTS9; BAIAP2L1; BAIAP2; DGKB;	GO:0009617~response to bacterium	25	92	27.1739130434783	0.011427849771294	0.2080666612973	1	1	0.999999999999988	0.999999999999988	1
down	SOX1; PLA2G10; SPRY2; SYNGR1; LRAT; SLC25A5; NEFH; RARG; SSTR1; PIGA; VEGFC; EPS8; KLF5; INA; BSPRY; ILDR1; NUP35; PMM1; ABCG4; SOX17; B3GNT2; MRPL15; KDM5B; FZD4; MPC1; SHMT1;	GO:1990830~cellular response to leukemia inhibitory factor	26	97	26.8041237113402	0.0115423006387836	0.209627703889948	1	1	0.999999999999988	0.999999999999988	1
up	CD160; HLA-E; HLA-G; HLA-F; KIR2DL4;	GO:0002729~positive regulation of natural killer cell cytokine production	5	8	62.5	0.0117631061655008	0.752156875394051	1	1	0.999999999574447	0.999999999574447	1
down	APOE; APOD; GSTP1; S100A7; HYAL1; HYAL2; NUDT15;	GO:0000302~response to reactive oxygen species	7	13	53.8461538461538	0.0121140238069098	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	SNAI2; BMP4; MSX1; MSX2; HEYL; TMEM100; HEY2;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	7	13	53.8461538461538	0.0121140238069098	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	AKR1B15; HSD3B1; HSD17B2; STAR; HSD17B12; DHRS11; HSD17B8;	GO:0006703~estrogen biosynthetic process	7	13	53.8461538461538	0.0121140238069098	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	HACD2; ELOVL1; ELOVL4; TECR; HACD3; ELOVL6; HACD1;	GO:0042761~very long-chain fatty acid biosynthetic process	7	13	53.8461538461538	0.0121140238069098	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	GJA5; GATA4; ISL1; TGFB2; TBX5; SMO; HEY2;	GO:0060413~atrial septum morphogenesis	7	13	53.8461538461538	0.0121140238069098	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	TBX3; EPHA2; MSX2; CCL11; DDR1; KDM5B; LRP5;	GO:0060444~branching involved in mammary gland duct morphogenesis	7	13	53.8461538461538	0.0121140238069098	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	NKX2-8; S100B; CCK; CNP; MAP2; NEFH; STMN1; FGFR2; PTPRZ1; CTNNA2; RAB10; CNTN4; PARD3; PARD6B; VAX2; BAIAP2; NTNG1; AFG3L2; SLITRK3; SLITRK6; ISL2; ISL1;	GO:0007409~axonogenesis	22	78	28.2051282051282	0.0121281425853795	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	MAPK13; IL33; EGFR; LDLR; S100A8; SERPINE1; S100A9; PLA2G2A; FABP4; ITGA2; MDK; CCL1; IL12B; AGTR1; WNT5A; CX3CL1; HYAL2; IL18; NLRP10; TSLP; MGST2; TRPV4;	GO:0050729~positive regulation of inflammatory response	22	78	28.2051282051282	0.0121281425853795	0.215444206851231	1	1	0.999999999999988	0.999999999999988	1
down	FOXE1; CTSB; DIO3; IYD; DIO2; SLC5A5; DUOX2; DUOX1;	GO:0006590~thyroid hormone generation	8	17	47.0588235294118	0.0134064013441099	0.23360414370727	1	1	0.999999999999988	0.999999999999988	1
down	KCNK10; KCNK6; KCNK2; KCNK3; KCNK1; KCNK7; KCNK15; KCNK5;	GO:0030322~stabilization of membrane potential	8	17	47.0588235294118	0.0134064013441099	0.23360414370727	1	1	0.999999999999988	0.999999999999988	1
down	CTSV; KRT36; CD109; AQP3; KRT84; GRHL1; SERPINB13; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	8	17	47.0588235294118	0.0134064013441099	0.23360414370727	1	1	0.999999999999988	0.999999999999988	1
down	TH; FOSL1; CCND1; MAOB; AVPR1A; CDKN1A; STAR; HSD3B1;	GO:0051412~response to corticosterone	8	17	47.0588235294118	0.0134064013441099	0.23360414370727	1	1	0.999999999999988	0.999999999999988	1
down	SDC4; HES1; USH1G; HES5; ADGRV1; MKS1; VANGL2; USH1C;	GO:0060122~inner ear receptor cell stereocilium organization	8	17	47.0588235294118	0.0134064013441099	0.23360414370727	1	1	0.999999999999988	0.999999999999988	1
down	DRD1; DRD5; GRIA1; STXBP1; SORCS2; PICK1; PLK2; SHANK2;	GO:0060292~long-term synaptic depression	8	17	47.0588235294118	0.0134064013441099	0.23360414370727	1	1	0.999999999999988	0.999999999999988	1
up	CNR2; MILR1; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	4	5	80	0.0137529337993987	0.842749221152041	1	1	0.999999999574447	0.999999999574447	1
up	PSMB11; IRF1; SATB1; TNFSF8;	GO:0043374~CD8-positive, alpha-beta T cell differentiation	4	5	80	0.0137529337993987	0.842749221152041	1	1	0.999999999574447	0.999999999574447	1
down	BMP5; DDR1; TCF15; SHROOM2; RDH10; STRA6;	GO:0043583~ear development	6	10	60	0.0138615912398045	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	ONECUT2; HOXD9; HOXD10; ETV1; NTRK2; ISL2;	GO:0048935~peripheral nervous system neuron development	6	10	60	0.0138615912398045	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	ITPKA; ITGA3; MTMR2; CTTN; TANC1; PICK1;	GO:0097062~dendritic spine maintenance	6	10	60	0.0138615912398045	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4F2; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	6	10	60	0.0138615912398045	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	PSCA; PATE4; LYNX1; SLURP1; LYPD6; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	6	10	60	0.0138615912398045	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	AP4M1; RAMP2; RAMP3; TOM1L1; NGFR; CLTB; NSF; TMED10; AP1S1; CTTN; TMED2; SEC23B; RIMS1; GPIHBP1; EXPH5; SYTL5; SNX33; AP3S1; SORCS2; MLPH; BCAP29; MYO6; RIMS2; KCNIP3; RAB25; TBC1D3E; SAR1B; RAB6C; RAB38; RAB3B; RAB14; RAB26; ARL14; STX12; RAB40AL; RAB17; IFT22; COPB2; VPS29; PICK1; RAB11A; RAB3C; VPS26A; RAB9A; ARF4; TBC1D8B; SNX31; RAB22A; GRTP1; ARL4D; TBC1D3K; STX19; RAB7B; RAB5A; SEC31A; TMED7; TBC1D3F; RAB1A; ARL1; RAB10; RAB13; RAB6A; TMED3; USP6NL; RAB2A; ARFIP2; RAB18;	GO:0006886~intracellular protein transport	67	317	21.1356466876972	0.0138923908535549	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	FZD6; WNT5A; FZD4; FZD9; FZD7; FRZB; FZD5; FZD10; SFRP2;	GO:0035567~non-canonical Wnt signaling pathway	9	21	42.8571428571429	0.013952448344988	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
down	ADRA2A; ADRA1A; DRD1; ADRA2C; ADRA1D; ADRA1B; ADRA2B; DRD5; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	9	21	42.8571428571429	0.013952448344988	0.237114708103499	1	1	0.999999999999988	0.999999999999988	1
up	TRAV27; PGLYRP1; LTA; HLA-A; FGR; RNASE2; RNASE3; DEFA4; HLA-E; CD36; TNFSF8; CAMP; GSDMD; DEFA3; IL27RA; LYG2; RNASE6; PGLYRP2; P2RX7; CARD9; GBP7; TNFRSF14;	GO:0050830~defense response to Gram-positive bacterium	22	95	23.1578947368421	0.0140395917670206	0.84852984761774	1	1	0.999999999574447	0.999999999574447	1
down	PRKRA; PENK; EIF2S1; SOD3; GSTP1; HSPA1B; GPX2; GPX3; NME2; GJB2; PRDX5; PRDX3; PYCR1; ETV5; PRKAA2; CYCS; PRDX1; DHRS2; KEAP1; NFE2L2; PNPT1; GPX8; ERO1A; NOX5; NOX4;	GO:0034599~cellular response to oxidative stress	25	94	26.5957446808511	0.0140842093500164	0.238029658482569	1	1	0.999999999999988	0.999999999999988	1
down	MATN2; SOX1; PEX7; ASTN1; DCLK1; GFRA3; CCK; NR2F2; ITGA3; AXL; NKX2-1; CXCL12; YWHAE; NKX6-1; PTK2; CDK5R2; NTRK2; VAX1; SH3RF1; DNER; NDNF; APBB2; PEX13; NDN; ADGRL3; CELSR1; MARK1; DCDC2;	GO:0001764~neuron migration	28	109	25.6880733944954	0.0141350879410147	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
up	LYN; NCKAP1L; MEF2C; PKN1; TNFSF13B; PPP2R3C; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	8	21	38.0952380952381	0.0143166619271992	0.853582600308144	1	1	0.999999999574447	0.999999999574447	1
down	DRD5; ADRA1A; ADRA1D; ADRA1B;	GO:0001994~norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	PRODH; GOT2; ALDH4A1; HOGA1;	GO:0019470~4-hydroxyproline catabolic process	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	FKBP4; DMRT3; SIX4; DMRT1;	GO:0046661~male sex differentiation	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	BMP4; BMP7; WNT5A; SULF1;	GO:0060686~negative regulation of prostatic bud formation	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; RARG; ALDH1A3; SOX9;	GO:0070384~Harderian gland development	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	ANXA8; PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	TJP1; ANGPT1; OCLN; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	4	4	100	0.0143512115719355	0.238132262924321	1	1	0.999999999999988	0.999999999999988	1
down	CDK2AP1; CLDN3; FGF19; CHEK2; EGFR; HRAS; ERBB2; ANXA2; RAP2A; BMP2; BMP4; EFNA1; CCND1; EDNRB; FLT4; KDR; CHRNA7; THPO; SOX9; EFNA5; HSPA2; WNT3A; TEK; PTK2; GPNMB; ANGPT1; NTRK2; RSPO1; IL34; KNDC1; PROM2; CLDN19; ITLN1; RARRES2; CARD14; TREM2; LIMCH1; VEGFC;	GO:0001934~positive regulation of protein phosphorylation	38	161	23.6024844720497	0.0148034948906524	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	NKX2-8; COBL; ZMPSTE24; ONECUT2; OTC; ASS1; HRAS; PKM; PTN; UGT1A1; ACAT1; MPST; AK4; WNT4; HMGCS1; HES1; AACS; LSR; PCSK9; GATA6; MET;	GO:0001889~liver development	21	75	28	0.0149297962811131	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	PTGES; CXCL13; S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	5	7	71.4285714285714	0.0150337753826916	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	EZR; PLS1; CDHR2; CDHR5; USH1C;	GO:0032532~regulation of microvillus length	5	7	71.4285714285714	0.0150337753826916	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; IGSF3; FGFR2; SOX9; FOXC1;	GO:0032808~lacrimal gland development	5	7	71.4285714285714	0.0150337753826916	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; BMP4; APCDD1; WNT10A; DMRT3;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	5	7	71.4285714285714	0.0150337753826916	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	PROM1; WT1; CD24; FOXC2; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	5	7	71.4285714285714	0.0150337753826916	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
down	SPINK1; ANXA8; SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	5	7	71.4285714285714	0.0150337753826916	0.245003558189802	1	1	0.999999999999988	0.999999999999988	1
up	IFNG; CD36; HLA-G; CD40LG; CCR7; IRF8; IRF5; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	9	26	34.6153846153846	0.0154174010500905	0.88125031535422	1	1	0.999999999574447	0.999999999574447	1
up	F2; PF4; PRKCB; LCK; FYN; GP1BA; LYN; PF4V1; GP9; PTPN6; CD40LG; FCER1G; GP5; P2RX1; GNA12; PRKCQ; LCP2; TRPC3; DGKK; PIK3R6; TREML1; PIK3R5; CLEC1B;	GO:0030168~platelet activation	23	102	22.5490196078431	0.0156799673998246	0.88125031535422	1	1	0.999999999574447	0.999999999574447	1
up	F2; F9; KNG1; F11; GP1BA; GP9; GP5;	GO:0007597~blood coagulation, intrinsic pathway	7	17	41.1764705882353	0.0157794140781921	0.88125031535422	1	1	0.999999999574447	0.999999999574447	1
up	APOBEC3H; APOBEC3F; APOBEC3D; INPP5K; APOBEC3G; APOBEC3C; AICDA;	GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	7	17	41.1764705882353	0.0157794140781921	0.88125031535422	1	1	0.999999999574447	0.999999999574447	1
down	SPTBN2; KALRN; PLIN3; NSF; RAB38; RAB10; RAB14; RAB11A; RAB1A; SPIRE1; TBC1D8B; VAMP3; BVES; SPIRE2; OSBPL1A; ADAMTS9; MYO5B; GOLT1B; SYT7; HSPA1B; HSPA2; CACFD1; ARL14; SYT10; ARL1; AP1S1; ARF4; SYT13; AP3S1; AP1S3; KIF1C; SYT8; SYT12; ARL4D;	GO:0016192~vesicle-mediated transport	34	141	24.113475177305	0.0158622015077899	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	WNT5A; GRHL3; DLG3; TP63; CELSR1; INTU; VANGL2;	GO:0001736~establishment of planar polarity	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	HOXA5; FLT4; YWHAZ; TCF15; CCBE1; NDN; JAG2;	GO:0003016~respiratory system process	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	APOE; FABP1; FABP4; PPARG; SLC27A4; MFSD2A; SLC27A6;	GO:0015909~long-chain fatty acid transport	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	FOXH1; JAG1; TBX2; SIX1; TFAP2B; EYA1; ADAMTS9;	GO:0035909~aorta morphogenesis	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	FOXP2; BMP4; ITGA8; DLG1; IHH; SMO; STRA6;	GO:0048745~smooth muscle tissue development	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; SNAI2; FABP4; PPARG; ADIG; FFAR4; AACS;	GO:0050872~white fat cell differentiation	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	SCNN1A; SCNN1B; SCNN1G; CYP4F2; CYP4A11; TFAP2B; CYP4F12;	GO:0055078~sodium ion homeostasis	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	MEIS2; ANXA3; EPHA2; SOX2; LUM; GATA6; TBC1D7;	GO:0070848~response to growth factor	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
down	MYO1C; CLDN5; SNAI2; GJA1; TJP1; FZD5; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	7	14	50	0.0161096435608584	0.254581185363263	1	1	0.999999999999988	0.999999999999988	1
up	CRTAM; CD2; IL15; CCR2; TBX21; PRELID1;	GO:0045580~regulation of T cell differentiation	6	13	46.1538461538462	0.0167716610007042	0.924957104188834	1	1	0.999999999574447	0.999999999574447	1
down	APOE; S100A9; HSPA5; NME1; NCK1; ADCYAP1; PTN; MDK; NME2; ITGA3; EPHA3; WNT5A; DYNLT1; CX3CL1; CNTN1; PTK6; DPYSL3; NFE2L2; NTRK2; PLPPR5; PLK5; DAB2IP; NDNF; NDRG4; FUT9; STYXL1; ROR1; TWF1;	GO:0010976~positive regulation of neuron projection development	28	111	25.2252252252252	0.0170216221674016	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
down	TMPRSS2; F12; CTSE; IHH; PCSK9; KLK6; MYRF; AFG3L2;	GO:0016540~protein autoprocessing	8	18	44.4444444444444	0.0171395953005354	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
down	NFIB; GLI2; BMP7; EN2; BMP5; HNF1B; SMAD1; GBX2;	GO:0030902~hindbrain development	8	18	44.4444444444444	0.0171395953005354	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
down	ALOX12B; GSTA1; GSTP1; ALOX12; CYP2J2; ELOVL1; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	8	18	44.4444444444444	0.0171395953005354	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
down	LGI1; SLC1A3; GRIK2; RIMS1; NMU; CLSTN2; RIMS2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	8	18	44.4444444444444	0.0171395953005354	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
down	PLXNA2; BMP7; BMP5; RIPPLY3; ISL1; SIX1; EYA1; SIX4;	GO:0060037~pharyngeal system development	8	18	44.4444444444444	0.0171395953005354	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
down	CXCL10; SERPINE1; CCL1; S100A7; CXCL12; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	8	18	44.4444444444444	0.0171395953005354	0.262891145565566	1	1	0.999999999999988	0.999999999999988	1
up	S1PR4; CALCA; PTH; GHRH; PF4; GNAI2; PTGER2; PTGIR; GLP1R; ADCY7; MC1R; GPR65; GPHA2; CALCB; TBXA2R; ADGRE1; ADGRG5; PTGER4; ADGRE2; ADGRE3; PTGDR; ADGRE4P; RXFP2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	23	103	22.3300970873786	0.0171466576455084	0.933963623851642	1	1	0.999999999574447	0.999999999574447	1
down	PITX3; REN; TFF1; CYP1A1; TH; GOT1; GAL; PPARG; LRP11;	GO:0035902~response to immobilization stress	9	22	40.9090909090909	0.0173768096667749	0.265414408738752	1	1	0.999999999999988	0.999999999999988	1
down	RASSF10; FZD9; MDK; NES; LHX2; WNT3A; ELL3; DLL4; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	9	22	40.9090909090909	0.0173768096667749	0.265414408738752	1	1	0.999999999999988	0.999999999999988	1
up	PIK3CD; NCR3; NCR1; IFNB1; ITGB2; CD2; IL2; IL21R;	GO:0030101~natural killer cell activation	8	22	36.3636363636364	0.0175960963366687	0.946755817529052	1	1	0.999999999574447	0.999999999574447	1
down	DCTN6; SPTBN2; ZW10; SEC31A; CNIH1; TGFA; PROS1; CD59; FOLR1; AREG; ARF4; COPB2; GRIA1; NSF; TMED10; RAB2A; RAB1A; DYNLL1; ANK2; COL7A1; DCTN2; TMED2; ATL2; MCFD2; TFG; SEC22A; SEC16B; CAPZA3; GORASP1; COG4; ACTR10; NRBP1; TMED7; TMED3; SAR1B; IER3IP1; CTAGE3P; TRAPPC6B; CTAGE4; BCAP29; TRAPPC3; CTAGE1; CTAGE8; KDELR2;	GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport	44	196	22.4489795918367	0.0184981281985893	0.280779280619336	1	1	0.999999999999988	0.999999999999988	1
up	CRTAM; IFNG; FGR; IL10; PTGER4; CLEC6A; RGCC; IL26; CD14;	GO:0050715~positive regulation of cytokine secretion	9	27	33.3333333333333	0.0185066095766108	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	ATP1A2; SCNN1B; SCNN1G; SLC10A7; SLC10A2; SLC13A2; SCN5A; FXYD3; NDUFA9; SLC5A12; SLC10A6; CATSPER4; SLC5A8; SLC4A11; SLC5A5; SLC38A4; NEDD4L; SLC38A3; SLC6A15; SLC13A4; SLC5A1;	GO:0006814~sodium ion transport	21	77	27.2727272727273	0.0186598931752172	0.28147909105839	1	1	0.999999999999988	0.999999999999988	1
down	SCD; FH; ADRB3; FABP4; PRLR; GJA1; ADCYAP1; ACHE; CPT2; ACADL; GATM; MFAP2; ESRRG; LCN2; FABP5; CAV1; IL18; HADH; FFAR4; TRPM8; DIO2; ELOVL6; EBF2; PEMT; YBX2;	GO:0120162~positive regulation of cold-induced thermogenesis	25	97	25.7731958762887	0.018968185882086	0.284952109310926	1	1	0.999999999999988	0.999999999999988	1
down	LAMA5; BMP7; FGF7; FGFR2; LAMA1; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	6	11	54.5454545454545	0.0190384152606411	0.285419855888995	1	1	0.999999999999988	0.999999999999988	1
down	EML1; MID1; OBSL1; GAPDH; CDK1; CNP; MAPT; MAP2; NEFH; WEE1; PTK2; CAMSAP2; CRMP1; MARK1; CAMSAP3; PARD3; TACC2; TUBB6; EFCAB11; TUBB4B; EML2; CALML6; TUBG1; TUBAL3; MAP7; CALML3; CALML5; TUBA1C; TUBB8;	GO:0000226~microtubule cytoskeleton organization	29	118	24.5762711864407	0.0201196113235632	0.297957976213661	1	1	0.999999999999988	0.999999999999988	1
up	CD19; PLCL2; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.0208558336838998	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	HLA-B; HLA-A; HLA-E; HLA-G;	GO:0042270~protection from natural killer cell mediated cytotoxicity	4	6	66.6666666666667	0.0208558336838998	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	PTH; MEF2C; MAP3K3; LEF1;	GO:0071864~positive regulation of cell proliferation in bone marrow	4	6	66.6666666666667	0.0208558336838998	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	IRF4; BATF; SLAMF6; LY9;	GO:0072540~T-helper 17 cell lineage commitment	4	6	66.6666666666667	0.0208558336838998	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	PIK3CD; PECAM1; PRTN3; JAML;	GO:0072672~neutrophil extravasation	4	6	66.6666666666667	0.0208558336838998	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	CTSV; NGFR; SEMA3F; NRTN; AFG3L2; NTF4; NTF3;	GO:0021675~nerve development	7	15	46.6666666666667	0.0209547893636115	0.304762783154836	1	1	0.999999999999988	0.999999999999988	1
down	CCL21; TGFB2; ADAM9; SFRP2; FOXC2; FERMT1; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	7	15	46.6666666666667	0.0209547893636115	0.304762783154836	1	1	0.999999999999988	0.999999999999988	1
down	SOX18; GJA5; FOXC1; TBX2; FOXC2; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	7	15	46.6666666666667	0.0209547893636115	0.304762783154836	1	1	0.999999999999988	0.999999999999988	1
down	OBSL1; MYL2; PDGFRA; CSRP3; ACTC1; FHOD3; MYOM3;	GO:0055003~cardiac myofibril assembly	7	15	46.6666666666667	0.0209547893636115	0.304762783154836	1	1	0.999999999999988	0.999999999999988	1
down	RBP4; HOXA11; WNT5A; LHX1; FOXL2; TGFB2; MYOCD;	GO:0060065~uterus development	7	15	46.6666666666667	0.0209547893636115	0.304762783154836	1	1	0.999999999999988	0.999999999999988	1
up	BNIP3L; IFNA21; IFNA5; IFNB1; IFNG; IFNW1; RNASE2; IRF1; PRF1; OPRK1; IFNAR2; DEFA3; IRF9; IRF5; AGBL4; APOBEC3H; NLRP9; APOBEC3F; LILRB1; RNASE6; APOBEC3D; ISG20; RTP4; TRIM34; UNC93B1; CARD9; IL21; APOBEC3G; EXOSC5; TLR8; TLR7; PYCARD; POLR3K; AICDA; IFITM1; IFITM2; TLR9; APOBEC3C;	GO:0051607~defense response to virus	38	198	19.1919191919192	0.021219044621314	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	LDLR; APOE; GJA5; HOXA1; FOXC1; HES1; FOXC2; STRA6; NOTCH3;	GO:0048844~artery morphogenesis	9	23	39.1304347826087	0.0213745340175908	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	KPNA7; ETV2; CAPN2; NEK2; ELF3; MED21; HORMAD1; SPIC;	GO:0001824~blastocyst development	8	19	42.1052631578947	0.0215644328911424	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	WNT9B; TBX3; PDGFRA; WT1; BMP5; HOXD13; DHCR24; LGR4;	GO:0030539~male genitalia development	8	19	42.1052631578947	0.0215644328911424	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	HACD1; ACSL3; HSD17B12; HACD2; ELOVL1; ELOVL4; ELOVL6; TECR;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	8	19	42.1052631578947	0.0215644328911424	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	LAMA5; CDK1; LAMA1; RAB14; NFE2L2; LAMA3; RACGAP1; SOX17;	GO:0045995~regulation of embryonic development	8	19	42.1052631578947	0.0215644328911424	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	UNC13B; GABRB3; GABRA5; NTF4; GABRB2; ISL1; SULF1; SLITRK6;	GO:0060384~innervation	8	19	42.1052631578947	0.0215644328911424	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	ADCY6; ACE; AGTR1; P2RY2; GCLC; FOXC1; FOXC2; ACE2;	GO:0097746~regulation of blood vessel diameter	8	19	42.1052631578947	0.0215644328911424	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
up	HBQ1; HBG1; HBG2; HBA1; HBM; IPCEF1;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.0216732199392102	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	IL15; IL2; PRKCQ; SLAMF6; IL21; LY9;	GO:0032740~positive regulation of interleukin-17 production	6	14	42.8571428571429	0.0216732199392102	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD4; CD3E; CD80; CD86; PRKCQ; IRF4;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	6	14	42.8571428571429	0.0216732199392102	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	DHRS2; HSD3B1; AKR1C1; AKR1C3; AKR1C2;	GO:0008207~C21-steroid hormone metabolic process	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	SULT1C2; INMT; CYP1A1; VCAM1; AOC1;	GO:0009308~amine metabolic process	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	CEACAM1; PTN; EMP2; PTK2; RHOJ;	GO:0010594~regulation of endothelial cell migration	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	PLPP3; CEACAM5; PTPRU; TJP2; XG;	GO:0034109~homotypic cell-cell adhesion	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	SULT1A3; MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	EGFR; AXL; NHLH2; TYRO3; TIMP4;	GO:0042698~ovulation cycle	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	GOT2; AGXT; ALDH4A1; HOGA1; GRHPR;	GO:0046487~glyoxylate metabolic process	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	ATP2C2; MSX1; WNT3; WNT4; WNT7B;	GO:0061180~mammary gland epithelium development	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	BMP4; FOLR1; TGFB2; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	GABRA1; AOC1; GABRB3; HRH1; GABRB2;	GO:0071420~cellular response to histamine	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	DKK1; C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
down	FOXE1; TGFB2; CEP55; TP63; COLEC10;	GO:1904888~cranial skeletal system development	5	8	62.5	0.0217783537864433	0.305189560450715	1	1	0.999999999999988	0.999999999999988	1
up	TNFSF14; CORO1A; NCKAP1L; TCIRG1; P2RX7; SLC39A3; GPR174; SIT1; PPP2R3C;	GO:0043029~T cell homeostasis	9	28	32.1428571428571	0.0220210344461533	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	DCDC2C; SOCS6; UNC13B; MCF2L; DCLK1; PLXNB1; EFS; TRAF3IP2; KALRN; SMPD2; RGS11; TGFA; ERBB2; HSPB1; CXCL1; MYZAP; STMN1; IGFBP5; GUCY1A2; ADRA1A; ADRA1B; TEC; PSEN2; YWHAE; GUCY2D; ARHGEF5; STK3; DEPDC1; MAGI3; CSPG4; ASB18; NET1; ARHGEF28; DEPTOR; DEPDC1B; BLNK; ASB5; ACOT11; APBB2; SPSB4; WNK4; DEPDC7; STAC; RACGAP1; SDCBP2; ARHGEF4; SPHK1; WSB2; MARK1; DCDC2; CARHSP1; WNK2; ASB4; DMRT1; STYXL1; MAST4; MOK; MAPK13; SGK2; CHEK1; MAPK4; RPS6KA6; NRBP1; STK32A; DGKB; GCOM1; NRG2; PPP1R1C; PRKAA2; TSSK1B; MELK; TUFT1; HUNK; MAPK6; RPS6KB2;	GO:0035556~intracellular signal transduction	75	371	20.2156334231806	0.0220699745145004	0.30868368569036	1	1	0.999999999999988	0.999999999999988	1
up	IL18RAP; EOMES; SPN; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	5	10	50	0.0225639080998109	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	PTPN6; ZFP36L2; FCRL3; TLR9; IKZF3;	GO:0045577~regulation of B cell differentiation	5	10	50	0.0225639080998109	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	EYA2; DUSP14; PTPRF; PTPRD; PTPRG; PTPRZ1; PTPN3; CDC25C; PTPN13; MTMR2; PTPRR; PTPN14; CDKN3; DUSP5; PTPN21; PTPN20; HACD2; SSH3; PTPRU; EYA1; DUSP9; DUSP15; DUSP13; PALD1; PTPRQ;	GO:0035335~peptidyl-tyrosine dephosphorylation	25	99	25.2525252525253	0.0229012660696621	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	PDCD6IP; RACGAP1; ANLN; RTKN;	GO:0000915~actomyosin contractile ring assembly	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	EYA2; HOXA11; EYA1; SIX2;	GO:0007501~mesodermal cell fate specification	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	HMGCR; ACAT1; MCCC2; CROT;	GO:0015936~coenzyme A metabolic process	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	TNC; AKR1C3; PTGFR; AKR1C2;	GO:0071799~cellular response to prostaglandin D stimulus	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	LMNA; PTN; WNT5A; CTNNBIP1;	GO:0072201~negative regulation of mesenchymal cell proliferation	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	CACNA1G; ANK2; SCN5A; HCN4;	GO:0086046~membrane depolarization during SA node cell action potential	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.0231231368135199	0.317932244586645	1	1	0.999999999999988	0.999999999999988	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0233718210122583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0233718210122583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CAT; DRD2; IL10;	GO:0014854~response to inactivity	3	3	100	0.0233718210122583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	HLA-A; HLA-E; CLEC4A;	GO:0036037~CD8-positive, alpha-beta T cell activation	3	3	100	0.0233718210122583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.0233718210122583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0233718210122583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	KCNU1; CACNA1G; KCNQ2; KCNK5; CLIC3; CLCN2; KCNQ4; KCNK10; KCNV1; CATSPER4; KCNH5; TMEM37; KCNB2; CLIC6; NEDD4L; KCNS3; KCNF1; KCNK15; HCN3; KCNK6; KCNK7; HCN4; CLCA3P; KCNJ3; KCNJ16; KCNJ8; KCNJ5; KCNJ4;	GO:0034765~regulation of ion transmembrane transport	28	115	24.3478260869565	0.0241864974225681	0.330066575106859	1	1	0.999999999999988	0.999999999999988	1
up	IL2RA; CD74; GATA3; CD27; ZAP70; RHOH; PIK3R6;	GO:0045582~positive regulation of T cell differentiation	7	19	36.8421052631579	0.0244487742971391	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; IL1A; IL1RN; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; PSMD2; PSMD5; PSMB7; PSMD1; IL1RL2; FBXW11;	GO:0070498~interleukin-1-mediated signaling pathway	24	95	25.2631578947368	0.0253068084926662	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	SOX18; FLT4; PTPN14; CCBE1; PDPN; FOXC2;	GO:0001946~lymphangiogenesis	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	AK4; UQCC2; SLC25A23; COX7A1; COX7A2; COX7A2P2;	GO:0002082~regulation of oxidative phosphorylation	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	DLL1; BMP4; BMP5; WNT5A; HNF4A; SMO;	GO:0003323~type B pancreatic cell development	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	APOA1; APOE; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	DIO3; CHST9; DIO2; CHST8; DUOX2; DUOX1;	GO:0042446~hormone biosynthetic process	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; FGF7; ADAM9; HAS2; HBEGF; EPB41L4B;	GO:0051549~positive regulation of keratinocyte migration	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	ADRA1A; CACNB3; CACNA2D1; TRPM1; JPH2; JPH1;	GO:0060402~calcium ion transport into cytosol	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	PLXNB1; GABRA1; GABRB3; WNT5A; GABRA2; GABRB2;	GO:1904862~inhibitory synapse assembly	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	TERT; TBX3; EPCAM; GJA1; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	RAMP2; CEACAM1; CD34; KDR; TMEM100; ASB4;	GO:2001214~positive regulation of vasculogenesis	6	12	50	0.0253905896331728	0.3358273458547	1	1	0.999999999999988	0.999999999999988	1
down	PLD2; BCAR3; DIRAS3; YWHAQ; ARFIP2; RRAD; RAB38; PLD1; DOCK1; KNDC1; RAPGEF4; RAPGEF5; RERG; DNAJA3; DOCK6; RAB6C; RAB18; RGL1; HACD3; RAPGEFL1; VAV3; ARHGAP32;	GO:0007264~small GTPase mediated signal transduction	22	85	25.8823529411765	0.0255564026947882	0.336073010882451	1	1	0.999999999999988	0.999999999999988	1
up	TAPBP; HLA-B; HLA-H; HLA-A; HLA-C; HLA-E; HLA-G; HLA-F; B2M;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	9	29	31.0344827586207	0.0259885600076265	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	PLK1; CDC20; MAD2L1; TRIP13; AURKB; TTK; ZW10; BUB1; BUB1B;	GO:0007094~mitotic spindle assembly checkpoint	9	24	37.5	0.0259914293354322	0.340688376262101	1	1	0.999999999999988	0.999999999999988	1
down	PTGES; MIF; EDN2; PLA2G4A; PTGIS; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	TACSTD2; PTPRG; PFN2; PTPRR; DAB2IP; MARVELD3; STRAP;	GO:0010633~negative regulation of epithelial cell migration	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	CYP27B1; CXCL10; SPP1; BMP7; STC1; CYP24A1; AQP3;	GO:0033280~response to vitamin D	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	PSMD3; CHEK2; PSMD2; NEDD4L; PSMD1; FAM83D; FAF1;	GO:0042176~regulation of protein catabolic process	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	INHA; INHBA; BMP4; BMP7; CDKN1A; CDKN2B; DYNLL1;	GO:0042326~negative regulation of phosphorylation	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	ALOX15B; CYP27B1; TRIM16; NME2; FOXC1; OVOL2; H2AFY2;	GO:0045618~positive regulation of keratinocyte differentiation	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	DLL1; FOXA1; ISL1; SIX1; DMRTA2; EYA1; ISL2;	GO:0048665~neuron fate specification	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	CAMSAP2; CDC20; KNDC1; CSMD3; MFSD2A; RAB17; MARK1;	GO:0050773~regulation of dendrite development	7	16	43.75	0.0267251539378318	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	FGF5; PDGFRA; EPCAM; MSX1; MSX2; HNF4A; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	8	20	40	0.0267384418707818	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	F12; PLAU; PLAT; HRG; SERPINB2; SERPINE1; PROS1; ANXA2;	GO:0042730~fibrinolysis	8	20	40	0.0267384418707818	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	CCL21; CLDN7; TF; EPCAM; DUOXA2; CCL19; DUOX2; DUOX1;	GO:2000147~positive regulation of cell motility	8	20	40	0.0267384418707818	0.343692542427074	1	1	0.999999999999988	0.999999999999988	1
down	GLI2; BMP2; BMP4; ADRA2B; ADRA2C; HOXD3; ETV5; NBL1; PCP4; FOXG1; FOXA1; IRX3; NKX6-1; DUOXA1; VWC2; GDF6; BRINP3; SH3GL3; HEYL; IMPACT; BRINP1;	GO:0045666~positive regulation of neuron differentiation	21	81	25.9259259259259	0.028256199222339	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
up	ITGB2; ALOX5; CCR6; ADAM8; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0297746887780583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	IL2RA; IL2RB; IL2RG; STAT5A; IL2;	GO:0038110~interleukin-2-mediated signaling pathway	5	11	45.4545454545455	0.0297746887780583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD74; CD3D; ZAP70; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	5	11	45.4545454545455	0.0297746887780583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD74; CD3E; CCR7; ZAP70; AIRE;	GO:0045060~negative thymic T cell selection	5	11	45.4545454545455	0.0297746887780583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD4; HLA-DRB1; CD74; FES; DCSTAMP;	GO:0045657~positive regulation of monocyte differentiation	5	11	45.4545454545455	0.0297746887780583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	LYN; CD19; BLK; GCSAML; GCSAM;	GO:0050855~regulation of B cell receptor signaling pathway	5	11	45.4545454545455	0.0297746887780583	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	APOBEC3F; AICDA; APOBEC3C; APOBEC2; APOBEC3H; APOBEC3G; APOBEC3D;	GO:0080111~DNA demethylation	7	20	35	0.029813216176196	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	SPI1; RELB; IKZF1; FLT3;	GO:0030098~lymphocyte differentiation	4	7	57.1428571428571	0.0298339628918016	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	BPI; CD33; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	4	7	57.1428571428571	0.0298339628918016	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CCL5; PDCD1; LGALS14; PRELID1;	GO:0070234~positive regulation of T cell apoptotic process	4	7	57.1428571428571	0.0298339628918016	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	BMP4; ERBB3; GATA4; FOXF1; TBX5;	GO:0003197~endocardial cushion development	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	GATA4; GRHL2; HEYL; DLL4; HEY2;	GO:0003208~cardiac ventricle morphogenesis	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SFN; KRT2; KDF1; EXPH5; PALLD;	GO:0003334~keratinocyte development	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	IDO1; HAAO; TDO2; IDO2; AADAT;	GO:0006569~tryptophan catabolic process	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PCCB; PC; PDZD11; MCCC1; MCCC2;	GO:0006768~biotin metabolic process	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	MATN2; CD9; TGFB2; CSPG4; NDN;	GO:0008347~glial cell migration	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	YES1; SLC2A1; EDNRA; OCLN; FFAR4;	GO:0010827~regulation of glucose transmembrane transport	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	APOA1; APOE; APOC1; APOA4; AGTR1;	GO:0010873~positive regulation of cholesterol esterification	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	KLK8; TNFRSF21; JAM2; MTMR2; TMEM98;	GO:0031642~negative regulation of myelination	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TCF21; WT1; WWTR1; HEYL; VANGL2;	GO:0032835~glomerulus development	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FN1; CXCL12; CX3CL1; COL16A1; FERMT2;	GO:0033622~integrin activation	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	APOA1; APOE; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	AKR1B10; AKR1A1; AKR1C3; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	AKR1B10; AKR1A1; AKR1C3; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PDCD6IP; MVB12A; TSG101; VTA1; CHMP5;	GO:0046755~viral budding	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ACAT1; HMGCS2; BDH1; AACS; HMGCLL1;	GO:0046951~ketone body biosynthetic process	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TULP3; GLI3; TGFB3; MTHFD1; HOXA1;	GO:0048702~embryonic neurocranium morphogenesis	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EZR; DLG1; MAD2L1; MISP; PARD3;	GO:0051660~establishment of centrosome localization	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EPS8; DPYSL3; BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051764~actin crosslink formation	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PYY; GATA4; GATA6; GATA5; PTK6;	GO:0060575~intestinal epithelial cell differentiation	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	RAMP2; LAMB4; LAMB2; LAMB3; NTN4;	GO:0070831~basement membrane assembly	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TIMM8A; BAG3; TIMM10; TIMM8B; TIMM13;	GO:0072321~chaperone-mediated protein transport	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	GSN; MCU; GDPD2; EFS; BCAR1;	GO:0090527~actin filament reorganization	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FZD9; SLC25A5; GCLC; BOK; TMEM14A;	GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	5	9	55.5555555555556	0.0302164341157853	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
up	FGF17; SH2D1A; GRAP2; FGF18; TSHB; GHRH; LTA; WNT1; ITGB2; CCL5; GATA1; CD33; TRH; SSTR3; CD70; TNFSF8; IL15; VIPR2; PTGIR; FASLG; CX3CR1; CCR5; IL2; CCL7; CRB1; LTB; GRAP; ZYX; LILRB2; SH3KBP1; FCRL2; TSPAN32; IL26; SIRPG; GPR101; PANX3; DRD2; PTH; ADRB2; OR56A4; FGFBP2; DRD3;	GO:0007267~cell-cell signaling	42	230	18.2608695652174	0.0303523138894156	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	CHP2; CPNE3; RASAL1; HSPA5; DPEP1; RYR1; WNT5A; AKR1C3; PRKAA2; ENDOG; SCN5A; LCE1D; ACER1; ADGRV1; LGMN; SLC25A23; SYT13; SYT12; SYT10; SYT7; SYT8;	GO:0071277~cellular response to calcium ion	21	82	25.609756097561	0.0311535213968834	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SERPINB7; TGFB3; BMP4; ITGA2; WNT4; IHH; HDAC2; CREB3L1; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	9	25	36	0.0312700620495779	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TERT; MT-CYB; CYB5A; CDK1; GOT1; DTYMK; HAAO; GCLC; GSS;	GO:0046686~response to cadmium ion	9	25	36	0.0312700620495779	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CYP27B1; CTSV; CTSB; SPP1; GJA1; PTN; GJB2; STC1; PTGIS;	GO:0046697~decidualization	9	25	36	0.0312700620495779	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EPN2; EGFR; LDLR; TGFA; PMP2; TF; CHRM2; CLTB; RALA; CFTR; AREG; RAB5A; YWHAQ; SFN; BTC; WNT5A; YWHAE; YWHAZ; OCRL; CTTN; DHCR24; TRIP10; VAMP3; FNBP1L; EPGN; BAIAP2L2; ARPC1A; HBEGF; SLC2A8; FZD4; SAR1B;	GO:0061024~membrane organization	31	134	23.134328358209	0.0313692706164124	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	AGRP; GPR37; POMC; NMB; CPE; ADCYAP1; NPY1R; NTS; NMU; NPY4R; GPR143; TYRO3; NPSR1; NPW; SORCS1; QRFPR; SORCS2; SORT1; SSTR1; GAL; GALR2; GPR1; GALR3; PYY; SSTR5; PENK;	GO:0007218~neuropeptide signaling pathway	26	108	24.0740740740741	0.0321012040523936	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CLDN1; TGFB3; TGFB2; CXADR; TJP1; OCLN; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	8	21	38.0952380952381	0.0327137599696957	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; BMP4; MYOCD; GATA6; TBX5; MESP1; NOX4; CBY1;	GO:0055007~cardiac muscle cell differentiation	8	21	38.0952380952381	0.0327137599696957	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CD34; MCAM; TBC1D8B; MYO1E; SULF1; ADGRF5;	GO:0003094~glomerular filtration	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	DNPH1; XDH; NT5C2; NT5C1A; NUDT15; GDA;	GO:0006195~purine nucleotide catabolic process	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	MIPEP; CPZ; CPM; CPXM1; CPXM2; CPE;	GO:0006518~peptide metabolic process	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	NQO1; NOS1; NOS2; SPR; SLC7A2; ARG2;	GO:0006809~nitric oxide biosynthetic process	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ATP8B1; SCP2; AKR1C1; NR1H4; ARV1; AMACR;	GO:0008206~bile acid metabolic process	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EML2; MAP2; STMN1; CDH5; FKBP4; INPP5J;	GO:0031115~negative regulation of microtubule polymerization	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PFN2; ID1; CX3CL1; PFN3; SYNPO2; SYNPO2L;	GO:0032233~positive regulation of actin filament bundle assembly	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CLDN5; RAMP2; DDAH1; SLIT2; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ARF4; MAL; SHROOM2; SHROOM3; CELSR1; VANGL2;	GO:0045176~apical protein localization	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ERLIN1; APOC1; APOC3; CEACAM1; ACADL; ACADVL;	GO:0045717~negative regulation of fatty acid biosynthetic process	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	DTYMK; AK4; CMPK1; AK7; AK8; AK3;	GO:0046940~nucleoside monophosphate phosphorylation	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ID4; DLX1; DLX2; HES1; HES5; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; WNT4; FOXF1; MYOCD; GATA6; HEY2;	GO:0051145~smooth muscle cell differentiation	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EDNRA; LHX1; DLX6; STRA6; MKS1; FLRT3;	GO:0060322~head development	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EGFR; TFAP2A; INHBA; GRHL3; HDAC2; STRA6;	GO:0061029~eyelid development in camera-type eye	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FLRT2; SPINT2; COL4A1; CAV2; CAV1; FERMT1;	GO:0071711~basement membrane organization	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TERT; CHEK1; CHEK2; SERPINE1; CDKN1A; PLA2R1;	GO:0090399~replicative senescence	6	13	46.1538461538462	0.0330086066591873	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PLAU; SERPINE1; FCGR2B; MAPK8IP2; PCSK9; MUC4; HMGB1P1;	GO:0010469~regulation of signaling receptor activity	7	17	41.1764705882353	0.0334871499846077	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ALOX15B; PLA2G10; CSF2; PLA2G2A; AGTR1; PLA2G5; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	7	17	41.1764705882353	0.0334871499846077	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	APOA1; APOE; APOC1; APOC3; APOA4; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	7	17	41.1764705882353	0.0334871499846077	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	NDUFS4; NDUFS1; CYCS; COX10; SDHAF4; COX4I2; SLC25A13;	GO:0045333~cellular respiration	7	17	41.1764705882353	0.0334871499846077	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	GRM6; ATP2C2; LGALS3; CASR; CXCL12; STC1; TRPV3;	GO:0090280~positive regulation of calcium ion import	7	17	41.1764705882353	0.0334871499846077	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PPP1R3G; POMC; RBP4; NGFR; ADRA2A; NMB; FGFR4; IGFBP5; SSTR5; PCK1; PPARG; HNF4A; GCGR; CSRP3; PRKAA2; FOXA1; FAM3B; FABP5; ADGRF5; MCU; TFAP2B; BAD; CSMD1; TRPV4; BACE2; ADRA1B; GCKR;	GO:0042593~glucose homeostasis	27	114	23.6842105263158	0.0341859131672099	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ZMPSTE24; KCNK2; SCN5A; MYOCD;	GO:0003231~cardiac ventricle development	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	MOCS2; MOCOS; MOCS1; NFS1;	GO:0006777~Mo-molybdopterin cofactor biosynthetic process	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PTPRF; PTN; PTPRD; PTPRU;	GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	F12; CLEC3B; ENO1; PLGRKT;	GO:0010756~positive regulation of plasminogen activation	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	HACD2; TECR; HACD3; HACD1;	GO:0030497~fatty acid elongation	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	MOCS2; MOCOS; MOCS1; NFS1;	GO:0032324~molybdopterin cofactor biosynthetic process	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SLC9A3R1; CASR; SLC51B; STARD10;	GO:0032782~bile acid secretion	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PLD2; SYT7; RAB5A; WNT3A;	GO:0036465~synaptic vesicle recycling	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PKM; AGXT; HOGA1; SRR;	GO:0042866~pyruvate biosynthetic process	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	KRT76; ZDHHC21; ACER1; WNT10A;	GO:0048733~sebaceous gland development	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	APOC1; APOC3; SORT1; ANGPTL4;	GO:0051005~negative regulation of lipoprotein lipase activity	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ALOX15B; ALOX12B; ALOX12; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	GATA4; TGFB2; GATA6; TBX5;	GO:0051891~positive regulation of cardioblast differentiation	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CAPN1; IGFBP5; ELF3; CAV1;	GO:0060056~mammary gland involution	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	UNC13B; ZP4; RIMS1; EQTN;	GO:0060478~acrosomal vesicle exocytosis	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	LRP5; COL4A1; LAMA1; FZD4;	GO:0061304~retinal blood vessel morphogenesis	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CYP27B1; PHGDH; RIDA; EZH2;	GO:0070314~G1 to G0 transition	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CTNNA2; PFN2; WASF1; WASF3;	GO:0098885~modification of postsynaptic actin cytoskeleton	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CLDN5; CLDN3; CLDN1; EPHA2;	GO:1903348~positive regulation of bicellular tight junction assembly	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	NGFR; IL12A; IL12B; DLL4;	GO:1903588~negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	DLL1; FZD7; DKK1; BMP2;	GO:2000726~negative regulation of cardiac muscle cell differentiation	4	6	66.6666666666667	0.0345196200818086	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	OR2A2; OR2A14; FZD9; CCL21; CXCL11; GIPC1; RGS12; MCF2L; DEFB4A; GRM6; GPR37; CCL16; RGS5; PLXNB1; GPR39; ADCY6; GALR2; CXCL13; KALRN; FZD6; GALR3; RAMP2; RAMP3; FZD7; TULP3; RGS20; RGS11; PLEKHG5; KCNK2; ADGRL2; GNA14; GLP2R; POMC; PENK; VIP; GAST; APOA1; APOE; APOC3; CXCL10; ANXA1; CCK; CHRM2; GNAI3; ADRA2A; NMB; CXCL1; SAA1; PYY; CHRM1; PTHLH; ADRB3; EDN3; AREG; PDE6A; ADRA2B; ADCYAP1; ADRA2C; EDN2; DRD1; DRD5; CCL1; GAL; FSHR; EDNRB; ADRA1D; EDNRA; ACKR3; NPY1R; HTR1D; ADORA2B; GNA11; BDKRB2; AGTR1; GNA15; SSTR1; CALCR; NTS; CCKBR; MC5R; PTGER1; SSTR5; ADRA1A; HRH1; ADRA1B; APLNR; PPARG; AVPR1A; CASR; P2RY2; ADCYAP1R1; AKR1C3; PTGFR; LPAR6; GPR1; GPR4; XCR1; BDKRB1; GCGR; SCTR; CXCL12; NMU; RGS4; NPY4R; GPR143; AKR1C2; PDE1A; BCAR1; OR10A3; PROK1; DEFB1; SST; GNAI1; CX3CL1; CCL20; CXCL6; GPSM2; FGD1; CXCL9; ADCY2; PDE4C; ARHGEF5; GPR17; FZD5; HTR4; P2RY6; PLCB4; ACKR1; CALCRL; FFAR4; ADGRF1; GPR158; GPR157; ARHGEF16; ATRNL1; RGS7BP; NPSR1; PREX2; TAS1R3; ADM2; NET1; ADGRG6; ARHGEF25; ARHGEF19; ADGRA3; ADGRF5; ADGRF4; ADGRF2; NGEF; NPW; TMEM145; GPRC5A; OR2I1P; OR10A6; OR51E1; ADGRV1; RAPGEF4; ARHGEF26; QRFPR; OXGR1; SORT1; CCL13; LPAR4; CCL19; SMO; HCAR1; GPR62; P2RY12; ADGRL3; ADGRL4; RXFP1; GPRC5C; ARHGEF4; CELSR1; OR6C2; LPAR3; RAPGEFL1; VAV3; FZD4; FZD10; APLN; OR9I1; GNG4; CCL14; OR7C2; GPR26; MRGPRX4; CCL11; GPR50; CGB7; OR10K1; GPR87; OR13A1; CCL26; OR9Q2; MRGPRX3; CCL18; CCL22; OR5P3; GPR78; MRGPRX2; GNGT1; GNG12; CCL17; OR5P2;	GO:0007186~G protein-coupled receptor signaling pathway	205	1152	17.7951388888889	0.0348798042085957	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CYP4F2; CYP4A11; CYP4F12;	GO:0003095~pressure natriuresis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ZMPSTE24; PPP1R13L; ADAMTS9;	GO:0003229~ventricular cardiac muscle tissue development	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CHRM2; CHRM1; GNA15;	GO:0007207~phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	BAG3; HMGCR; BMP7;	GO:0010664~negative regulation of striated muscle cell apoptotic process	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	AXL; EMX2; TYRO3;	GO:0021885~forebrain cell migration	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FOXH1; BMP2; GATA4;	GO:0035054~embryonic heart tube anterior/posterior pattern specification	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FZD6; MSX1; MSX2;	GO:0035880~embryonic nail plate morphogenesis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TST; PNPT1; MRPL18;	GO:0035928~rRNA import into mitochondrion	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TMEM79; DUOX2; DUOX1;	GO:0042335~cuticle development	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CBR3; CYP4F2; CYP4F11;	GO:0042376~phylloquinone catabolic process	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	DKK1; SFRP2; MESP1;	GO:0042662~negative regulation of mesodermal cell fate specification	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	AGXT; GPT; GPT2;	GO:0042853~L-alanine catabolic process	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PLEKHA7; KIFC3; CAMSAP3;	GO:0045218~zonula adherens maintenance	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; RBP4; TP63;	GO:0048807~female genitalia morphogenesis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	GAL; MSX2; TGFB2;	GO:0051795~positive regulation of timing of catagen	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	GLI3; TGFB3; MSX2;	GO:0060364~frontal suture morphogenesis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SPDEF; AGR2; HOXA5;	GO:0060480~lung goblet cell differentiation	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	HOXA5; WNT5A; WNT2B;	GO:0060638~mesenchymal-epithelial cell signaling	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SPINT2; GRHL2; ST14;	GO:0060672~epithelial cell morphogenesis involved in placental branching	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ISL1; MESP1; SOX17;	GO:0060913~cardiac cell fate determination	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	HES1; SOX17; MKS1;	GO:0061009~common bile duct development	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SLIT3; SLIT2; ROBO2;	GO:0061364~apoptotic process involved in luteolysis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	HYAL2; AQP3; HAS2;	GO:0070295~renal water absorption	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CD34; ISL1; TSLP;	GO:0071657~positive regulation of granulocyte colony-stimulating factor production	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	LHX1; HES1; HES5;	GO:0072049~comma-shaped body morphogenesis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	LHX1; HES1; HES5;	GO:0072050~S-shaped body morphogenesis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	IRX1; IRX3; HES5;	GO:0072086~specification of loop of Henle identity	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	HNF1B; SIX1; SIX4;	GO:0072095~regulation of branch elongation involved in ureteric bud branching	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	BMP4; SOX9; SIX1;	GO:0072193~ureter smooth muscle cell differentiation	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	HES1; HES5; LGR4;	GO:0072282~metanephric nephron tubule morphogenesis	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	SIX1; EYA1; TBX5;	GO:0072513~positive regulation of secondary heart field cardioblast proliferation	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CACNA2D1; SCN5A; TRPM4;	GO:0086048~membrane depolarization during bundle of His cell action potential	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	CACNB3; CACNA2D1; CAV1;	GO:0098903~regulation of membrane repolarization during action potential	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	EIF4E; EIF4A3; CYFIP1;	GO:0099578~regulation of translation at postsynapse, modulating synaptic transmission	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	NOS1AP; TXN; ACE;	GO:2000170~positive regulation of peptidyl-cysteine S-nitrosylation	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ITGA8; NPNT; MYOCD;	GO:2000721~positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	PROM1; CD24; LHX1;	GO:2000768~positive regulation of nephron tubule epithelial cell differentiation	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
down	ACSL3; CAPN2; RAB38;	GO:2001247~positive regulation of phosphatidylcholine biosynthetic process	3	3	100	0.0350388721338331	0.35879215350507	1	1	0.999999999999988	0.999999999999988	1
up	IGKV3-20; IGHM; HLA-A; RNASE3; DEFA4; HLA-E; CAMP; DEFA3; RNASE6;	GO:0019731~antibacterial humoral response	9	31	29.0322580645161	0.0353853219975069	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	TXK; FYN; LYN; LCK; FES; HCK; FGR; BLK; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	9	31	29.0322580645161	0.0353853219975069	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	SASH3; CD3E; HLA-E; GATA3; CD40LG; FCER1G; PRKCQ;	GO:0032753~positive regulation of interleukin-4 production	7	21	33.3333333333333	0.0359159535033868	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	TNFRSF1B; CCR2; CLC;	GO:0002724~regulation of T cell cytokine production	3	4	75	0.0374350156802759	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	HLA-A; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0374350156802759	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0374350156802759	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0374350156802759	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	CFAP69; WIPF3; OVOL1; CTSV; GJB3; SUN1; PGM3; PTTG1; ROS1; ACE; ZNF35; CCNB1; GJA1; TSPAN8; FSHR; AXL; SSTR1; HOXA11; KRT9; CETN2; ADCYAP1R1; SOX9; HSPA2; FOXA3; NME5; TPPP2; CCNA1; CDK16; B4GALNT1; BNC1; TYRO3; ADIG; PRDX4; WFDC2; RGN; SPA17; TRIP13; ODF4; MORN2; MEIG1; NKAPL; TXNDC8; SHISA6; SPATA19; TXNRD3; HORMAD1; DZIP1; TDRP; POC1A; MNS1; TCP11; IFT81; BAD; FOXJ1; RPL39L; PIWIL1; MYCBP; GAL3ST1; DPCD; KIFC1; LGR4; TEX15; RACGAP1; VCX; TP63; SOX17; GORASP2; ELL3; BCL2L10; NPAP1; RAI14; THEG; DUSP13; JAG2; YBX2; DMRT1; PRSS21; GGT5; HIST1H1T;	GO:0007283~spermatogenesis	79	407	19.4103194103194	0.0390493197964994	0.396521674317444	1	1	0.999999999999988	0.999999999999988	1
down	SLIT2; APOE; DCN; NR2F2; STC1; DAB2IP; DLL4; ADAMTS9;	GO:0010596~negative regulation of endothelial cell migration	8	22	36.3636363636364	0.0395360551058472	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	TBX3; GLI2; TGFB3; ITGA2; HOXD9; SOX9; WNT3A; CAV1;	GO:0030879~mammary gland development	8	22	36.3636363636364	0.0395360551058472	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	ARF4; FAT1; VANGL2; DLG2; DLG3; PARD3; LRRC1; DLG1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	8	22	36.3636363636364	0.0395360551058472	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	CYP27B1; REG1A; CAV1; TFAP2B; SGCD; JPH2; TRPV6; S100A14;	GO:0055074~calcium ion homeostasis	8	22	36.3636363636364	0.0395360551058472	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	NR2F2; ADRA1A; AVPR1A; NMU; ACE;	GO:0003084~positive regulation of systemic arterial blood pressure	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	BMP4; PAX7; FOXA1; WNT3A; SMO;	GO:0021904~dorsal/ventral neural tube patterning	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	ALOX15B; GLI3; SOX9; FKBP4; ANXA1;	GO:0030850~prostate gland development	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	LHX1; TMED2; RIPPLY2; NRARP; EPB41L5;	GO:0032525~somite rostral/caudal axis specification	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	GOT1; NPPC; PPARG; CYGB; ERRFI1;	GO:0032966~negative regulation of collagen biosynthetic process	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	ETFA; ACADL; ETFB; ACADVL; ETFDH;	GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	SNAI2; HRG; SERPINE1; MUC1; ACER2;	GO:0033629~negative regulation of cell adhesion mediated by integrin	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	APOA1; APOE; APOC3; APOA4; P4HB;	GO:0034378~chylomicron assembly	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	EZR; DLG1; SGCD; SEH1L; MIOS;	GO:0034629~cellular protein-containing complex localization	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	FGFR3; MMP16; STC1; HMGA2; IHH;	GO:0035988~chondrocyte proliferation	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	DSCAM; UNC5C; PTK2; UNC5D; UNC5B;	GO:0038007~netrin-activated signaling pathway	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	IGFBP5; SERPINB1; NKX6-1; ANGPTL8; BAD;	GO:0044342~type B pancreatic cell proliferation	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	LMNA; CDK1; CCNB1; FHL2; HEY2;	GO:0055015~ventricular cardiac muscle cell development	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	RBP4; AXL; WNT5A; LHX1; TYRO3;	GO:0060068~vagina development	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	ATP8B1; GABRB3; GABRA5; GABRB2; USH1C;	GO:0060119~inner ear receptor cell development	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	HOXC11; BMP4; BMP7; HOXA11; HYAL1;	GO:0060272~embryonic skeletal joint morphogenesis	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	PDLIM4; PDLIM3; PDLIM5; PRICKLE4; PDLIM1;	GO:0061061~muscle structure development	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
down	HSPB1; MET; SEMA5A; LGMN; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	5	10	50	0.040448391838447	0.397996912146228	1	1	0.999999999999988	0.999999999999988	1
up	MS4A1; ORAI1; ORAI3; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.040756811689981	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	GPR31; IL10; B2M; TLR9;	GO:0002237~response to molecule of bacterial origin	4	8	50	0.040756811689981	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	IL2RG; STAT4; IL21; IL21R;	GO:0038114~interleukin-21-mediated signaling pathway	4	8	50	0.040756811689981	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CSF1R; PRTN3; MYADM; PARD6A;	GO:0045217~cell-cell junction maintenance	4	8	50	0.040756811689981	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	ATP1B1; C7; ATP1A2; ATP1B3; NEDD4L; ATP12A; ATP4A;	GO:0006883~cellular sodium ion homeostasis	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; BMP4; AVPR1A; LHX1; HES1; SCN5A; HES5;	GO:0021537~telencephalon development	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	TUBB4B; PRDX1; IL18; RAET1G; RAET1E; ULBP3; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	DSP; DES; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	PSMD14; APOE; USP14; PSME3; RHBDF1; NUDT15; UCHL5;	GO:0061136~regulation of proteasomal protein catabolic process	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	DLL1; FGF1; PKM; FUT1; TJP1; SMAD1; JMJD8;	GO:1903672~positive regulation of sprouting angiogenesis	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	GSTP1; TGFB3; PPARG; CDKN1A; CNN1; MYOCD; APLN;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	7	18	38.8888888888889	0.0412963300114716	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	MCIDAS; LAMA5; ABLIM3; ONECUT2; GSN; CCNO; NME5; RAB1A; OCRL; FNBP1L; TCTN3; ARMC9; TMEM17; DZIP1; SPAG16; TTC8; DNAH5; TCTEX1D2; IFT81; FOXJ1; WDR34; IFT43; FOPNL; TMEM237; WWTR1; CCDC113; RAB17; IFT46; PARVA; MKS1; PLA2G3; EHD3; ATXN10; DCDC2; INTU; B9D1; ATP6V1D; TEKT5; TEKT4; CDKN3;	GO:0060271~cilium assembly	40	187	21.3903743315508	0.0415363813299038	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
up	SH2B2; F13A1; F2; F9; SERPINA1; IFNA21; IFNA5; IFNB1; F11; FYN; GP1BA; LYN; IRF1; GP9; GATA1; CD36; GATA2; GATA3; PRTN3; FCER1G; PRKAR2B; GP5; P2RX1; HBG1; HBG2; GNA12; ITPK1; NFE2; DTNBP1; P2RX4; P2RX7; VKORC1;	GO:0007596~blood coagulation	32	171	18.7134502923977	0.0415482698560998	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	GZMB; GZMA; PRF1; GZMH; GZMM; MMD;	GO:0019835~cytolysis	6	17	35.2941176470588	0.0418610466034653	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	ADA; CD4; CD3E; ZAP70; TRAT1; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	6	17	35.2941176470588	0.0418610466034653	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	RAMP3; ANXA2; NSG1; NSF; VAMP3; BVES;	GO:0001921~positive regulation of receptor recycling	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	MPDU1; FUT3; ST6GALNAC5; ST6GALNAC1; B3GALT5; B3GALNT1;	GO:0009312~oligosaccharide biosynthetic process	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	IGF1; GSTP1; CX3CL1; FFAR4; TREM2; ERRFI1;	GO:0032691~negative regulation of interleukin-1 beta production	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	PTGIS; RNLS; NAPRT; SLC5A8; NAXE; NUDT12;	GO:0034356~NAD biosynthesis via nicotinamide riboside salvage pathway	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	TMED10; TMED2; CTAGE4; CTAGE1; CTAGE8; CTAGE3P;	GO:0035459~vesicle cargo loading	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	NPR3; EDNRB; BTC; HYAL2; TFAP2B; HAS2;	GO:0035810~positive regulation of urine volume	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	SAA1; LGALS3; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	AGR2; EGFR; EPHB3; SFRP2; STRA6; VANGL2;	GO:0048546~digestive tract morphogenesis	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	TGFB2; FOXC1; SMAD1; TENM4; FOXC2; NDRG4;	GO:0060038~cardiac muscle cell proliferation	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	SLC9A3R1; DRD1; DRD5; GNA14; GNA15; GNA11;	GO:0060158~phospholipase C-activating dopamine receptor signaling pathway	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	TRIM16; ASS1; NME2; IGFBP5; CPS1; PNPT1;	GO:0060416~response to growth hormone	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
down	RAMP3; MMP3; CALCR; CHRNA7; MMP12; MMP13;	GO:1904645~response to amyloid-beta	6	14	42.8571428571429	0.0419634278815509	0.400490179036867	1	1	0.999999999999988	0.999999999999988	1
up	PIK3CD; CD4; DBH; PTAFR; TXK; BATF; NFATC1; NFATC3;	GO:0001816~cytokine production	8	27	29.6296296296296	0.0422387186956504	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	GNGT2; CABP4; UNC119; TRPC3; PLEKHB1; RHO; GPR88; OPN1SW;	GO:0007602~phototransduction	8	27	29.6296296296296	0.0422387186956504	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	IFNG; CD4; HLA-DRB1; CSF1R; SPI1; IL15; CEBPE;	GO:0030225~macrophage differentiation	7	22	31.8181818181818	0.0427884553685253	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	GABRB3; GABRA2; GABRB2; GABRA4; GABRG3; GABRA5; GABRA1; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	9	27	33.3333333333333	0.0439620972458623	0.41522286156797	1	1	0.999999999999988	0.999999999999988	1
down	DRD5; GJA5; BDKRB1; VEGFC; RNLS; ADM2; APLN; NOS2; NOS1;	GO:0045776~negative regulation of blood pressure	9	27	33.3333333333333	0.0439620972458623	0.41522286156797	1	1	0.999999999999988	0.999999999999988	1
down	PGK1; ALDOA; GAPDH; ENO1; GPI; PFKM; PKM; HK1; TPI1;	GO:0061621~canonical glycolysis	9	27	33.3333333333333	0.0439620972458623	0.41522286156797	1	1	0.999999999999988	0.999999999999988	1
down	GADD45A; AGTR1; CDKN1A; AKR1C3; XDH; ROMO1; NFE2L2; ACE2; NOX4;	GO:2000379~positive regulation of reactive oxygen species metabolic process	9	27	33.3333333333333	0.0439620972458623	0.41522286156797	1	1	0.999999999999988	0.999999999999988	1
down	PSMD11; PSMD12; PSMD14; PSMD3; PSMD10; HSPB1; SCGB1A1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMD8; PSMA6; PSME3; PSMC5; PSMC6; YWHAZ; PSMD2; PSMD5; PSMB7; PSMD1; EXOSC4; IGF2BP1; CARHSP1;	GO:0043488~regulation of mRNA stability	26	112	23.2142857142857	0.0441729067194259	0.416674925011018	1	1	0.999999999999988	0.999999999999988	1
down	GALR2; CXCL13; NMB; SAA1; PDGFRA; GJA1; ADCYAP1; EDN2; CCL1; EDNRB; CD24; EDNRA; BDKRB2; AGTR1; CCKBR; ADRA1A; AVPR1A; BDKRB1; NMU; FFAR4; PLCZ1; SPPL3; TRPM4; TRPV4; LPAR3; ADRA1D; GPR33; PTGER1; ADRA1B; XCR1; PTGFR; CALCR; ACKR3;	GO:0007204~positive regulation of cytosolic calcium ion concentration	33	150	22	0.0452691295795267	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	PDLIM1; NDUFS8; LIAS; IDH1; NDUFB4; NQO1; PSMB5; PRDX5; PRDX3; GCLC; GSS; NDUFA6; PON2; DHCR24; ETFDH; SCARA3; NAPRT; CYGB; RBPMS; SGK2; DUOX2; DUOX1; PRDX4; PRDX1;	GO:0006979~response to oxidative stress	24	102	23.5294117647059	0.0462118588165498	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	FOXP2; LRP5; FGFR2; WNT5A; SOX9; FOXF1; IHH; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	TLCD2; SLC9A3R1; BAIAP2L2; TLCD1; A4GALT; BAIAP2L1; BAIAP2; FER1L6;	GO:0007009~plasma membrane organization	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	PRMT5; OBSL1; RCC1; CDC25C; CAV2; NEK2; PKMYT1; FBXO43;	GO:0007088~regulation of mitotic nuclear division	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	PROM1; DSCAM; TSPAN12; TFAP2A; LHX1; FJX1; RDH13; TFAP2B;	GO:0010842~retina layer formation	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CYP11A1; FDXR; CYP51A1; EBPL; CYP39A1; CYP26A1; CYP26C1; ARV1;	GO:0016125~sterol metabolic process	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	KALRN; OPHN1; KANK1; ARHGEF25; EPS8L1; EPS8L2; EPS8L3; EPS8;	GO:0035023~regulation of Rho protein signal transduction	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	FAM107A; ANXA1; GSTP1; ADCYAP1; UGT1A1; STC1; ISL1; SSTR5;	GO:0071385~cellular response to glucocorticoid stimulus	8	23	34.7826086956522	0.0472436187368703	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
up	RPS6KA5; CRYBA1; IL10; BTK; CLEC4A;	GO:0001818~negative regulation of cytokine production	5	13	38.4615384615385	0.0481245705414969	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD4; IL2RB; IL2RG; IL15; STAT5A;	GO:0035723~interleukin-15-mediated signaling pathway	5	13	38.4615384615385	0.0481245705414969	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	CD27; NCKAP1L; BTK; INPP5D; PPP2R3C;	GO:0045579~positive regulation of B cell differentiation	5	13	38.4615384615385	0.0481245705414969	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
up	RGS13; RGS14; PLEK; CCL5; RGS2;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	5	13	38.4615384615385	0.0481245705414969	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	BMP4; EPHA2; SEMA5A; NRARP;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CYP1A1; CYP2E1; CYP3A5; CYP4A22;	GO:0002933~lipid hydroxylation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	ITPKA; PPIP5K1; IMPA2; IMPA1;	GO:0006020~inositol metabolic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	MAPT; PCK1; MDH2; EHHADH;	GO:0006475~internal protein amino acid acetylation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	DDAH1; FAH; NOS1; NOS2;	GO:0006527~arginine catabolic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	PHGDH; PSPH; SRR; PSAT1;	GO:0006564~L-serine biosynthetic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	MDH2; MDH1; NUDT12; MDH1B;	GO:0006734~NADH metabolic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CYP27B1; CYP26A1; CYP24A1; CYP26C1;	GO:0006766~vitamin metabolic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	ITGA2; EPHA8; VEGFC; CSPG4;	GO:0006929~substrate-dependent cell migration	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	TH; DRD1; NHLH2; MAPK8IP2;	GO:0007617~mating behavior	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	TBX3; HOXD8; WNT5A; FZD5;	GO:0008595~anterior/posterior axis specification, embryo	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CYP1A1; TH; STAR; LCN2;	GO:0009635~response to herbicide	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	GRID2; OPHN1; CBLN1; KNDC1;	GO:0021707~cerebellar granule cell differentiation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	NFASC; CD9; ANK2; UGT8;	GO:0030913~paranodal junction assembly	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	SLC22A3; POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	IDO1; NOS1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	FOXN1; ITGB4; HOXC13; KRT84;	GO:0035878~nail development	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	SPIRE1; SNX33; SPIRE2; AURKB;	GO:0036089~cleavage furrow formation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	IYD; DIO2; CRYM; DIO3;	GO:0042403~thyroid hormone metabolic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	HOXA7; MSX2; GRHL2; TP63;	GO:0045617~negative regulation of keratinocyte differentiation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CA2; TPD52; CA9; RIMS1;	GO:0046903~secretion	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	MAPT; TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	TCF21; CTSV; SOX9; DMRT1;	GO:0060008~Sertoli cell differentiation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	FOXP2; ALDH1A3; USP46; AFG3L2;	GO:0060013~righting reflex	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	FGF10; WNT7B; FOXJ1; ERRFI1;	GO:0060428~lung epithelium development	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	SNAI2; LHX1; FOXJ1; RARG;	GO:0060429~epithelium development	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	YAP1; SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	RARG; TNC; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	IL33; CX3CL1; IL34; TREM2;	GO:0061518~microglial cell proliferation	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	AQP1; RHCG; RHBG; RHCE;	GO:0072488~ammonium transmembrane transport	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	BCAR3; EDNRB; EDNRA; BCAR1;	GO:0086100~endothelin receptor signaling pathway	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	ATP1B1; ATP1B3; WNK4; WNK2;	GO:1903288~positive regulation of potassium ion import across plasma membrane	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	AP4M1; RAB10; CAV1; PDZD11;	GO:1903361~protein localization to basolateral plasma membrane	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	CCL21; AXL; CXCL12; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	PENK; CCK; GJA1; NPAS2;	GO:2000987~positive regulation of behavioral fear response	4	7	57.1428571428571	0.0486208350865724	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
down	FOXE1; BHLHE40; TBX3; BIRC5; FOXP2; RBFOX2; ATP8B1; HR; FOXS1; GMNN; CRYAB; CSF2; TFAP2A; ENO1; TNP1; GLI3; BMP2; BMP4; FABP4; BMP7; WT1; NR2F2; YWHAQ; HOXA7; PHB; MSX2; SOX18; PPARG; ID1; WNT5A; HNF4A; NKX2-1; ID4; SOX9; GCLC; LHX1; HMGA2; FOXG1; PAX9; WNT4; FOXL2; PSMC5; PITX1; ELF3; MECOM; RUNX1T1; FOXM1; FOXF2; TBX2; HES1; NR0B2; EZH2; FOXD1; ZNF423; NKAPL; DEPDC1; DAB2IP; ZNF425; KCTD1; ERN2; NOSTRIN; CIART; DMBX1; TFAP2B; HDAC2; GATA6; CREB3L1; SFRP2; ATOH8; TSG101; MESP1; TCEAL7; SOX7; MTA3; LGR4; TRIM6; NKX6-2; CIPC; TP63; ZHX3; HMX1; HEYL; NDUFA13; DKK3; HEY2; KDM5B; SIX4; MAGEL2; FBXW11; ZHX1; CBY1; ZNF165; SIX2; ZNF488; OVOL1; SIX1; LDB2; ALX1; OVOL2;	GO:0045892~negative regulation of transcription, DNA-templated	99	530	18.6792452830189	0.0489375711011246	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
up	MPO; DEFA4; GNLY; DEFA3; HAMP; COTL1; CLEC6A; IL17RA;	GO:0050832~defense response to fungus	8	28	28.5714285714286	0.0490193213010902	0.964647684061169	1	1	0.999999999574447	0.999999999574447	1
down	PSMD11; PSMD12; PSMD14; SLC27A2; AGPAT2; SCAMP1; PSMD3; SYNGR1; CPNE3; IDH1; NFASC; PLAU; SERPINA3; PIGR; SLPI; ALDOA; CSTB; S100A8; GSN; S100A9; GPI; ANXA2; CAPN1; CTSB; GSTP1; CXCL1; HSPA1B; MGST1; PYGB; IMPDH2; ANXA3; CEACAM1; CD59; MIF; PKM; JUP; DSP; GM2A; LGALS3; AOC1; TCN1; RAB6A; AGA; NME2; SERPINB3; SERPINB1; CHRNB4; S100A7; S100A11; PRSS3; SERPINB6; PSMC2; CEACAM6; FRK; CRISP3; RAB10; RAB14; DYNLL1; DYNLT1; TUBB4B; CCT2; LCN2; TNFAIP6; FABP5; DSG1; CKAP4; PRDX4; PSMD2; PLD1; PKP1; FLG2; NAPRT; CYFIP1; HRNR; GGH; TMBIM1; PGM2; SERPINB12; PSMB7; PSMD1; VAT1; PTGES2; RAB18; NIT2; ACTR10; CALML5; KCMF1; LAMTOR3; DERA; ATP6V1D; HEBP2;	GO:0043312~neutrophil degranulation	91	483	18.8405797101449	0.0490683790570947	0.424117237912992	1	1	0.999999999999988	0.999999999999988	1
